<?DTDIdentifier.IdentifierValue http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd?>
<?DTDIdentifier.IdentifierType schema?>
<?SourceDTD.DTDName xocs-article.xsd?>
<?SourceDTD.Version 1.0?>
<?ConverterInfo.XSLTName ftrr2jats.xsl?>
<?ConverterInfo.Version 1?>
<?origin publisher?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Trends Biotechnol</journal-id>
    <journal-id journal-id-type="iso-abbrev">Trends Biotechnol</journal-id>
    <journal-title-group>
      <journal-title>Trends in Biotechnology</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0167-7799</issn>
    <issn pub-type="epub">1879-3096</issn>
    <publisher>
      <publisher-name>The Author(s). Published by Elsevier Ltd.</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7114124</article-id>
    <article-id pub-id-type="pii">S0167-7799(19)30173-8</article-id>
    <article-id pub-id-type="doi">10.1016/j.tibtech.2019.07.004</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Review</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Resources to Discover and Use Short Linear Motifs in Viral Proteins</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" id="au0005">
        <name>
          <surname>Hraber</surname>
          <given-names>Peter</given-names>
        </name>
        <xref rid="af0005" ref-type="aff">1</xref>
        <xref rid="cor1" ref-type="corresp">∗</xref>
      </contrib>
      <contrib contrib-type="author" id="au0010">
        <name>
          <surname>O’Maille</surname>
          <given-names>Paul E.</given-names>
        </name>
        <xref rid="af0010" ref-type="aff">2</xref>
      </contrib>
      <contrib contrib-type="author" id="au0015">
        <name>
          <surname>Silberfarb</surname>
          <given-names>Andrew</given-names>
        </name>
        <xref rid="af0015" ref-type="aff">3</xref>
      </contrib>
      <contrib contrib-type="author" id="au0020">
        <name>
          <surname>Davis-Anderson</surname>
          <given-names>Katie</given-names>
        </name>
        <xref rid="af0020" ref-type="aff">4</xref>
      </contrib>
      <contrib contrib-type="author" id="au0025">
        <name>
          <surname>Generous</surname>
          <given-names>Nicholas</given-names>
        </name>
        <xref rid="af0025" ref-type="aff">5</xref>
      </contrib>
      <contrib contrib-type="author" id="au0030">
        <name>
          <surname>McMahon</surname>
          <given-names>Benjamin H.</given-names>
        </name>
        <xref rid="af0005" ref-type="aff">1</xref>
      </contrib>
      <contrib contrib-type="author" id="au0035">
        <name>
          <surname>Fair</surname>
          <given-names>Jeanne M.</given-names>
        </name>
        <xref rid="af0020" ref-type="aff">4</xref>
      </contrib>
      <aff id="af0005"><label>1</label>Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87545, USA</aff>
      <aff id="af0010"><label>2</label>Biosciences Division, SRI International, 333 Ravenswood Ave, Menlo Park, CA 94025, USA</aff>
      <aff id="af0015"><label>3</label>Artificial Intelligence Center, SRI International, 333 Ravenswood Ave, Menlo Park, CA 94025, USA</aff>
      <aff id="af0020"><label>4</label>Biosecurity and Public Health, Los Alamos National Laboratory, Los Alamos, NM 87545, USA</aff>
      <aff id="af0025"><label>5</label>Global Security Directorate, Los Alamos National Laboratory, Los Alamos, NM 87545, USA</aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>∗</label>Correspondence:</corresp>
    </author-notes>
    <pub-date pub-type="pmc-release">
      <day>16</day>
      <month>8</month>
      <year>2019</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
    <pub-date pub-type="ppub">
      <month>1</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>16</day>
      <month>8</month>
      <year>2019</year>
    </pub-date>
    <volume>38</volume>
    <issue>1</issue>
    <fpage>113</fpage>
    <lpage>127</lpage>
    <permissions>
      <copyright-statement>© 2019 The Author(s)</copyright-statement>
      <copyright-year>2019</copyright-year>
      <license>
        <license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p>
      </license>
    </permissions>
    <abstract id="ab0005">
      <p>Viral proteins evade host immune function by molecular mimicry, often achieved by short linear motifs (SLiMs) of three to ten consecutive amino acids (AAs). Motif mimicry tolerates mutations, evolves quickly to modify interactions with the host, and enables modular interactions with protein complexes. Host cells cannot easily coordinate changes to conserved motif recognition and binding interfaces under selective pressure to maintain critical signaling pathways. SLiMs offer potential for use in synthetic biology, such as better immunogens and therapies, but may also present biosecurity challenges. We survey viral uses of SLiMs to mimic host proteins, and information resources available for motif discovery. As the number of examples continues to grow, knowledge management tools are essential to help organize and compare new findings.</p>
    </abstract>
    <abstract abstract-type="author-highlights" id="ab0010">
      <title>Highlights</title>
      <p>
        <list list-type="simple" id="l0005">
          <list-item id="li0005">
            <label>•</label>
            <p id="p0075">Short linear motifs (SLiMs) are patterns of three to ten consecutive AAs used by eukaryotic cells for tasks that include: signaling, localization, degradation, and proteolytic cleavage.</p>
          </list-item>
          <list-item id="li0010">
            <label>•</label>
            <p id="p0080">Viruses use SLiMs to their advantage, including interference with antiviral innate immune pathways.</p>
          </list-item>
          <list-item id="li0015">
            <label>•</label>
            <p id="p0085">Viral SLiMs can tolerate mutations, evolve quickly to modify host interactions, and co-occur in a modular manner or involve multiprotein complexes.</p>
          </list-item>
          <list-item id="li0020">
            <label>•</label>
            <p id="p0090">SLiMs are useful in synthetic biology, where minor edits can alter target specificity, modulate persistence, reprogram interactions with cell-signaling domains, and alter protein function in myriad other ways.</p>
          </list-item>
          <list-item id="li0025">
            <label>•</label>
            <p id="p0095">Aside from possible beneficial uses, for example, to produce better immunogens and develop therapeutic interventions against infectious disease, SLiMs may help characterize new and emerging threats to global health.</p>
          </list-item>
        </list>
      </p>
    </abstract>
    <kwd-group id="ks0005">
      <title>Keywords</title>
      <kwd>molecular mimicry</kwd>
      <kwd>short linear motifs</kwd>
      <kwd>immune modulation</kwd>
      <kwd>gene ontology</kwd>
      <kwd>host–pathogen interactions</kwd>
      <kwd>cell signaling</kwd>
    </kwd-group>
  </article-meta>
</front>
<body>
  <sec id="s0005">
    <title>How Viruses Do More with Less</title>
    <p id="p0100">Viruses exploit host cellular processes to replicate, and have developed myriad ways to subvert host immune defenses. <bold>Molecular mimicry</bold> (see <xref rid="gs0005" ref-type="list">Glossary</xref>) is a common and effective strategy, enabling a pathogen to usurp host protein function by resemblance <xref rid="bb0005" ref-type="bibr">1</xref>, <xref rid="bb0010" ref-type="bibr">2</xref>. Molecular mimicry varies over a continuum, from one extreme that includes sequence and structural similarity (i.e., orthologs) of entire proteins, to another extreme of chemical similarity at only a few localized sites, as is the case for <bold>short linear motifs (SLiMs)</bold>. The growing body of literature on SLiMs indicates that some important virus–host interactions can be attributed to a few well-chosen AAs <xref rid="bb0015" ref-type="bibr">3</xref>, <xref rid="bb0020" ref-type="bibr">4</xref>, <xref rid="bb0025" ref-type="bibr">5</xref>, <xref rid="bb0030" ref-type="bibr">6</xref>, <xref rid="bb0035" ref-type="bibr">7</xref>. Rather than devote entire proteins to one function, SLiMs enable multifunctional viral proteins. Interactions between globular virus and host proteins have picomolar affinities, while SLiMs have micromolar binding affinities with globular host proteins <xref rid="bb0040" ref-type="bibr">[8]</xref>. Moderate binding affinity of SLiMs facilitates disruption of signaling interactions, rather than competing for stable formation of persistent protein complexes. Synthetic biology practitioners can benefit from an introduction to how SLiMs enable viral interference with host cell functions and computational resources available for SLiM analysis.</p>
    <p id="p0105">Viral SLiMs are potentially useful in synthetic biology, to provide a toolkit for new functions, for example, to modulate immune responses or to complement and interact with newly developed <bold>adjuvants</bold> in a synergistic manner <xref rid="bb0045" ref-type="bibr">[9]</xref>. Research efforts to develop broad-spectrum antiviral compounds or design broadly cross-protective vaccine immunogens benefit directly from knowledge of gene products, protein functions, and motifs involved with viral immune interference. <italic>N</italic>-linked <bold>glycosylation</bold> of the <bold>PNG sequon</bold> is a well-known example used by viral glycoproteins as camouflage against immune recognition <xref rid="bb0050" ref-type="bibr">10</xref>, <xref rid="bb0055" ref-type="bibr">11</xref>. The distribution of <italic>N</italic>-linked glycosylation sites has recently been recognized as essential for the design of immunogens to induce broadly cross-reactive immune protection against such challenging viruses as HIV-1 <xref rid="bb0060" ref-type="bibr">12</xref>, <xref rid="bb0065" ref-type="bibr">13</xref>. Motifs associated with cellular trafficking (localization, transport, secretion, and sequestration) are readily edited to modify where expression products go, and change interaction profiles with other proteins <xref rid="bb0070" ref-type="bibr">[14]</xref>. In addition to motifs that stabilize the structure of immunogens, such as trimerization (‘foldon’) <xref rid="bb0075" ref-type="bibr">15</xref>, <xref rid="bb0080" ref-type="bibr">16</xref>, <xref rid="bb0085" ref-type="bibr">17</xref>, <xref rid="bb0090" ref-type="bibr">18</xref> and dimerization <xref rid="bb0095" ref-type="bibr">19</xref>, <xref rid="bb0100" ref-type="bibr">20</xref>
<bold>domains</bold>, motifs that interact with cellular processes for innate antiviral pathways could be used to enhance immunogenicity. While SLiMs in eukaryotic proteins have been discussed extensively, SLiM involvement in viral immunomodulation remains less thoroughly explored, and suggests new opportunities for use in engineered biotechnology applications.</p>
    <p id="p0110">The ability to transfer genetic components across species, or to introduce such components <italic>de novo</italic>, enables new functions. While such functions are generally well intended, some risk also exists for harmful effects. Subject to the technical advances of synthetic biology, such effects are not necessarily a taxonomically relevant property. It may be necessary to evaluate risks of new functions by other means than taxonomy or even protein functional evaluations. Instead, new methods are needed that assess functions at a finer resolution than the gene, whether by computational analysis or functional phenotypic assessments <xref rid="bb0105" ref-type="bibr">21</xref>, <xref rid="bb0110" ref-type="bibr">22</xref>, <xref rid="bb0115" ref-type="bibr">23</xref>. SLiM analysis might help with such assessments.</p>
  </sec>
  <sec id="s0010">
    <title>Viral Immunomodulatory Proteins</title>
    <p id="p0115">Viral proteins can modulate immunity in several ways, which include: shutdown of host macromolecular synthesis, inhibiting antigen production or apoptosis, and interference with such processes as antigen presentation by MHC, natural killer (NK) cell function, antiviral cytokines, or interferon responses. Each of these processes involves coordination among multiple components in host cells. Viral interference with these functions is frequently attributed to entire proteins, but in some important cases has been localized to SLiMs.</p>
    <sec id="s0015">
      <title>Signaling Interference</title>
      <p id="p0120">Because of their compact size, SLiMs are modular, rapidly evolvable sequence elements. Different instances of a given SLiM can vary in sequence while maintaining the overall functional profile, that is, the <bold>regular expression</bold> for the sequence motif, where a few positions are invariant while other positions tolerate numerous substitutions. Thus, partial sequence matches are sufficient for transient binding interactions with target domains, for example, signal transduction proteins. This observation led to the proposal of <italic>ex nihilo</italic> SLiM evolution – the evolution of a novel SLiM ‘from nothing’ – the appearance of a new functional module from a previously nonfunctional region of protein sequence <xref rid="bb0120" ref-type="bibr">[24]</xref>. Because hosts’ interaction networks are often conserved, SLiMs represent a significant vulnerability for opportunistic exploitation. These properties enable pathogens to acquire host-like SLiMs rapidly through <italic>ex nihilo</italic> convergent evolution, to rewire host interaction networks, and to acquire tropism and virulence traits needed for successful adaptation and propagation <xref rid="bb0125" ref-type="bibr">[25]</xref>. Over 200 motifs are known, with 2,400 validated instances, and many more motifs may await discovery <xref rid="bb0015" ref-type="bibr">3</xref>, <xref rid="bb0130" ref-type="bibr">26</xref>. Focus on viral motifs may reveal practical utility, to broaden the repertoire of tools available to reprogram molecular function in synthetic biology.</p>
      <p id="p0125">One example of how viral proteins use SLiMs to subvert host cell function is illustrated by Epstein–Barr virus (EBV), which persists in resting memory B cells of nearly all (&gt;95%) individuals throughout their adult lives <xref rid="bb0025" ref-type="bibr">[5]</xref>. Latent membrane protein 1 (LMP1) is central to EBV persistence. The cytoplasmic tail of this membrane-bound protein includes PxxPxP and PxQxT motifs that recruit signaling proteins (JAK3, that is, Janus kinase 3, and several TRAFs, tumor necrosis factor receptor-associated factors, respectively) <xref rid="bb0025" ref-type="bibr">[5]</xref>. Together, the motifs mimic the cytoplasmic domain of CD40 to activate nuclear factor-κB via intermediates, including a third motif YYD$ (where $ denotes the C terminus), the TRADD (tumor necrosis factor receptor-associated death domain) binding domain. The overall result is that LMP1 inhibits apoptosis and infected B cell proliferation, to confer viral persistence <xref rid="bb0025" ref-type="bibr">[5]</xref>. Other examples of viral SLiM contributions to motif mimicry involved with immune function include: protein degradation, transcription, translation, and transport into and out of the nucleus <xref rid="bb0025" ref-type="bibr">[5]</xref>.</p>
    </sec>
    <sec id="s0020">
      <title>Viral Gene Ontologies</title>
      <p id="p0130">Given the continued growth of this field <xref rid="bb0135" ref-type="bibr">[27]</xref>, established frameworks can manage and exploit this knowledge beyond catalogues of currently known motifs <xref rid="bb0025" ref-type="bibr">5</xref>, <xref rid="bb0035" ref-type="bibr">7</xref>, <xref rid="bb0140" ref-type="bibr">28</xref> or details on contributions of one viral protein (e.g., <xref rid="bb0070" ref-type="bibr">14</xref>, <xref rid="bb0145" ref-type="bibr">29</xref>). Work to use SLiMs in bioengineering can benefit from understanding viral protein function. This information is organized in viral knowledge bases, such as <bold>ViralZone</bold> (<xref rid="b0005" ref-type="boxed-text">Box 1</xref>
). Ontologies describe systematically the many different functional roles of viral proteins, including immune evasion. By promoting use of standard terms for relationships between concepts, an <bold>ontology</bold> arranges concepts into a framework that can be updated as knowledge grows. Protein function is captured broadly in such a framework, though the nuanced details of interactions with other molecules are not localized to domains or motifs.<boxed-text id="b0005"><label>Box 1</label><caption><title>The ViralZone Ontology Outlines Viral Protein Function</title></caption><p id="p0005">A bridge that links literature reports to GO term annotation, ViralZone is an online knowledge base that contains ‘textbook’ information about viral taxonomy, replication, genome organization, and virion structure, and provides links to viral sequence data <xref rid="bb0310" ref-type="bibr">62</xref>, <xref rid="bb0315" ref-type="bibr">63</xref>. Importantly, ViralZone staff collaborate with the GO Consortium to define entries for virus-specific molecular functions <xref rid="bb0315" ref-type="bibr">63</xref>, <xref rid="bb0320" ref-type="bibr">64</xref>, <xref rid="bb0325" ref-type="bibr">65</xref>, <xref rid="bb0330" ref-type="bibr">66</xref>. ViralZone cross-references its keywords with GO Consortium terms and UniProt <xref rid="bb0335" ref-type="bibr">[67]</xref> identifiers. This makes it possible to search for viral proteins by their functional role.</p><p id="p0010">ViralZone staff have developed GO concepts specifically for viruses, to represent the diversity of viral replication and processes involved with viral entry, replication, and egress <xref rid="bb0330" ref-type="bibr">[66]</xref>. ViralZone staff have also developed a detailed listing of virus–host interactions, with entries for 65 functions and 57 GO terms <xref rid="bb0320" ref-type="bibr">64</xref>, <xref rid="bb0325" ref-type="bibr">65</xref>. Each entry (‘keyword’) has a unique identifier. Unlike Enzyme Commission (EC) numbers <xref rid="bb0340" ref-type="bibr">[68]</xref>, ViralZone IDs are arbitrary numbers and do not indicate position in the concept hierarchy. Instead, organization of the keyword hierarchy is provided online. The web address <ext-link ext-link-type="uri" xlink:href="https://viralzone.expasy.org/886" id="ir0035">https://viralzone.expasy.org/886</ext-link> is an entry point into the ViralZone concept space (<xref rid="f0010" ref-type="fig">Figure I</xref>).<fig id="f0010"><label>Figure I</label><caption><p>ViralZone Summarizes What Is Known about Viral Proteins Involved in Virus–Host Interactions.</p><p>Blue text indicates a link to more detail. Shown is the vertebrate host–virus interactions page <xref rid="bb0320" ref-type="bibr">[64]</xref>. Also available are summaries for invertebrate, plant, and bacterial host–virus interactions.</p></caption><alt-text id="al0030">Figure I</alt-text><graphic xlink:href="b1_lrg"/></fig>
</p><notes notes-type="alt-text" specific-use="for-accessibility" id="al0025"><p>Alt-text: Box 1</p></notes></boxed-text></p>
      <p id="p0135"><bold>GO</bold> is an authoritative resource for annotating functions of gene sequences <xref rid="bb0150" ref-type="bibr">30</xref>, <xref rid="bb0155" ref-type="bibr">31</xref>. An example of interest is ‘evasion or tolerance by virus of host immune response’ <xref rid="bb0160" ref-type="bibr">[32]</xref> (<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/QuickGO/term/GO:0030683" id="ir0055">www.ebi.ac.uk/QuickGO/term/GO:0030683</ext-link>, <xref rid="f0005" ref-type="fig">Figure 1</xref>
). Concepts are hierarchically organized, and include a definition, synonyms, and lists of parents and children. Functional annotation in GO reflects the diverse effects of viral proteins on immune interference.<fig id="f0005"><label>Figure 1</label><caption><p>Immune-Evasion Concept Hierarchy.</p><p>Adapted from <ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/QuickGO/term/GO:0030683" id="ir0005">www.ebi.ac.uk/QuickGO/term/GO:0030683</ext-link><xref rid="bb0160" ref-type="bibr">[32]</xref>. Most arrows indicate ‘is a’ relations, where the hierarchy is refined by specialization. Blue arrows indicate ‘part of’ relations, which relate to the symbiont process as parts to a whole.</p></caption><alt-text id="al0005">Figure 1</alt-text><graphic xlink:href="gr1_lrg"/></fig></p>
      <p id="p0140">Modulating <bold>autophagy</bold> is an example of recent advances in this research area <xref rid="bb0165" ref-type="bibr">33</xref>, <xref rid="bb0170" ref-type="bibr">34</xref>. A growing number of reports describe how virus proteins and SLiMs therein modulate autophagy to promote various aspects of their life cycle <xref rid="bb0170" ref-type="bibr">34</xref>, <xref rid="bb0175" ref-type="bibr">35</xref>. Both GO and ViralZone have developed concepts to detail autophagy processes, including positive and negative regulation of xenophagy, the selective autophagy of pathogens <xref rid="bb0165" ref-type="bibr">33</xref>, <xref rid="bb0170" ref-type="bibr">34</xref>, <xref rid="bb0175" ref-type="bibr">35</xref>.</p>
      <p id="p0145">Understanding the functional roles of SLiMs can help identify related mechanisms or processes, or possibly identify knowledge gaps where SLiMs may be posited but not yet identified. An overview of SLiM functions may also help to prioritize which are of greatest potential for use or abuse when artificially added to modify protein function. Databases and discovery tools are also useful to identify known and new SLiMs.</p>
    </sec>
  </sec>
  <sec id="s0025">
    <title>Motif Databases</title>
    <p id="p0150">Identification of shared structural features across divergent protein families led to analysis and identification of modular protein domains. Protein domains are used to categorize protein function, and the InterPro database <xref rid="bb0180" ref-type="bibr">[36]</xref> (<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/interpro" id="ir0060">www.ebi.ac.uk/interpro</ext-link>) aggregates information at this within-protein level. The identification of protein domains led to recognition of SLiMs as compact, small-scale functional modules <xref rid="bb0185" ref-type="bibr">[37]</xref>.</p>
    <p id="p0155"><bold>ELM</bold> is a database of eukaryotic motifs (<xref rid="b0010" ref-type="boxed-text">Box 2</xref>
), though its representation of viral–host interactions is not fully developed. At present, 264 ELM entries map to 648 GO terms. Most motifs map to multiple GO terms; the median is seven GO terms per motif and the maximum is 29 (MOD_Plk_1). Immune-associated function of the LIG_IRF3_LxIS_1 motif is involved in signal transduction responses to pathogen-associated molecular patterns; this motif maps to 25 GO terms, but none occur in the ViralZone vocabulary. In total, only three ELM entries utilize GO terms from ViralZone: LIG_BH_BH3_1, LIG_HCF-1_HBM_1, and LIG_Rb_pABgroove_1. These three motifs all map to the most general GO term, GO:0019048 (‘modulation by virus of host morphology or physiology’, a synonym of ‘virus–host interaction’). This underscores the prevalent mode of ELM motif discovery and annotation does not emphasize host–virus interactions, but rather systems-level interactions within eukaryotic cells. Thus, better integration of ViralZone–GO-term vocabulary with ELM or another domain-level representation of viral SLiMs is needed to promote potential utility for biotechnology.<boxed-text id="b0010"><label>Box 2</label><caption><title>Eukaryotic Linear Motif Resource Curates Confirmed Viral Motifs</title></caption><p id="p0015">ELM assigns motif classes to one of six functional categories <xref rid="bb0345" ref-type="bibr">69</xref>, <xref rid="bb0350" ref-type="bibr">70</xref>:</p><p id="p0020">(i) CLV, proteolytic cleavage sites;</p><p id="p0025">(ii) DEG, degradation sites, part of polyubiquitination;</p><p id="p0030">(iii) DOC, docking sites, involved in protein recruitment but not directly targeted by an active site;</p><p id="p0035">(iv) LIG, ligand binding sites, primarily for protein–protein interactions;</p><p id="p0040">(v) MOD, post-translational modification sites; and</p><p id="p0045">(vi) TRG, targeting sites for subcellular localization.</p><p id="p0050">ELM has also spun-off several specialized databases: phospho.ELM for phosphorylation sites with experimental evidence <xref rid="bb0355" ref-type="bibr">[71]</xref>, switches.ELM for conditional molecular switches, such as requiring that a site be modified <xref rid="bb0360" ref-type="bibr">[72]</xref>, and iELM, with an emphasis on protein–protein interactions <xref rid="bb0365" ref-type="bibr">[73]</xref>. A detailed tutorial provides orientation for ELM use <xref rid="bb0370" ref-type="bibr">[74]</xref>.</p><p id="p0055">ELM documents each motif class with a concise description of its function. For example, one type of nuclear localization signal (NLS), TRG_NLS_Bipartite_1 the ‘classic bipartite NLS’, which binds to importin-α for nuclear pore transfer and is utilized by the PB2 protein of influenza A, is documented here: <ext-link ext-link-type="uri" xlink:href="http://elm.eu.org/elms/TRG_NLS_Bipartite_1" id="ir0040">elm.eu.org/elms/TRG_NLS_Bipartite_1</ext-link>. The abstract and functional site descriptions summarize what is known about the motif.</p><p id="p0060">ELM provides a virus-specific summary at <ext-link ext-link-type="uri" xlink:href="http://elm.eu.org/viruses.html" id="ir0045">elm.eu.org/viruses.html</ext-link> and serves downloads in multiple formats from there or <ext-link ext-link-type="uri" xlink:href="http://elm.eu.org/downloads.html" id="ir0050">elm.eu.org/downloads.html</ext-link>. ELM presently contains 53 viral motif classes and 246 viral motif instances. Viral motif instances are distributed over the functional categories as follows: 4.5% CLV, 1.6% DEG, 4.1% DOC, 47.8% LIG, 26.5% MOD, and 15.5% TRG. Of the 246 instances, the most common (50, or 20.3%) are <italic>N</italic>-linked glycosylation sites from six distinct viruses. The most commonly represented viruses with motif instances in ELM are HIV-1 (11.8% of all entries) and severe acute respiratory syndrome-related coronavirus, that is, SARS-CoV (5.7%), though again, these are dominated by the <italic>N</italic>-linked glycosylation sites: 25 of 29 HIV-1 entries and 13 of 14 from SARS-CoV. More viral motif classes and instances will surely be added to ELM in time.</p><notes notes-type="alt-text" specific-use="for-accessibility" id="al0035"><p>Alt-text: Box 2</p></notes></boxed-text></p>
    <sec id="s0030">
      <title>Integration of Resources</title>
      <p id="p0160">Despite not using the ViralZone ontology, ELM documents other <bold>motif classes</bold> with GO terms that refer to ‘viral’, ‘virus’, ‘immune’, or ‘immunity’ (<xref rid="t0005" ref-type="table">Table 1</xref>
). Because the focus is motif function in the host cell context, ELM does not directly indicate how viral immune interference results. Further, the relative lack of viral motifs in ELM does not indicate their absence <italic>in vivo</italic>, but rather the evidence-based requirement for ELM inclusion.<table-wrap position="float" id="t0005"><label>Table 1</label><caption><p>Number of ELM Viral Motif Instances with Virus-Related or Immune-Related GO Terms</p></caption><alt-text id="al0010">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="center">Regular expression</th><th align="center">Viral instances</th><th align="center">Motif</th><th align="center">Role</th></tr></thead><tbody><tr><td align="center"><xref rid="tf6000" ref-type="table-fn">a</xref></td><td align="center">15</td><td align="center">LIG_Rb_LxCxE_1</td><td align="center">Binds retinoblastoma B pocket</td></tr><tr><td align="center">.P[TS]AP.</td><td align="center">13</td><td align="center">LIG_PTAP_UEV_1</td><td align="center">UEV domain binding PTAP motif</td></tr><tr><td align="center">[LM]YP.[LI]</td><td align="center">11</td><td align="center">LIG_LYPXL_S_1</td><td align="center">Endosomal sorting of membrane proteins</td></tr><tr><td align="center">[FVILMY].FG[DES]F</td><td align="center">8</td><td align="center">LIG_G3BP_FGDF_1</td><td align="center">Binds Ras GTPase activating SH3 domain</td></tr><tr><td align="center"><xref rid="tf6005" ref-type="table-fn">b</xref></td><td align="center">5</td><td align="center">LIG_KLC1_WD_1</td><td align="center">Binds kinesin light chain TPR region</td></tr><tr><td align="center">[LM]YP.[LI]</td><td align="center">2</td><td align="center">LIG_LYPXL_L_2</td><td align="center">Endosomal sorting of membrane proteins</td></tr><tr><td align="center">[DE]H.Y</td><td align="center">1</td><td align="center">LIG_HCF-1_HBM_1</td><td align="center">Binds transcriptional coactivator HCF-1</td></tr><tr><td align="center">..L.I(S)</td><td align="center">1</td><td align="center">LIG_IRF3_LxIS_1</td><td align="center">Interferon regulatory factor 3 binding site</td></tr><tr><td align="center">.[VILM]..[LM][FY]D.</td><td align="center">1</td><td align="center">LIG_Rb_pABgroove_1</td><td align="center">Binds retinoblastoma AB groove</td></tr><tr><td align="center"><xref rid="tf6010" ref-type="table-fn">c</xref></td><td align="center">0</td><td align="center">LIG_BH_BH3_1</td><td align="center">Binds BH domains to inhibit apoptosis</td></tr><tr><td align="center">EP[IL]Y[TAG]</td><td align="center">0</td><td align="center">LIG_CSK_EPIYA_1</td><td align="center">Binds C-terminal Src kinase SH2 domain</td></tr></tbody></table><table-wrap-foot><fn id="tf6000"><label>a</label><p id="np6000">([DEST]|ˆ).{0,4}[LI].C.E.{1,4}[FLMIVAWPHY].{0,8}([DEST]|$)</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf6005"><label>b</label><p id="np6005">[LMTAFSRI][ˆKRG]W[DE].{3,5}[LIVMFPA]</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf6010"><label>c</label><p id="np6010">....[LIFVYMTE][ASGC][ˆP]{2}L[ˆP]{2}[IVMTL][GACS][D][ˆP][FVLMI].</p></fn></table-wrap-foot></table-wrap></p>
      <p id="p0165">Related to the earlier observation, a review of how viruses use SLiMs to interfere with host cells <xref rid="bb0025" ref-type="bibr">[5]</xref> lists 52 examples that represent viral mimicry of host SLiMs (<xref rid="t0010" ref-type="table">Table 2</xref>
). Only 70% of these have corresponding ELM entries, though the SLiMs are known. The remaining 30% indicate that ELM does not fully capture all known viral motifs. This strong requirement by ELM for evidence-based motif classes and instances is not strictly a drawback. Indeed, the ELM creators are very aware that computational analysis alone is error prone and can yield misleading outcomes. In <xref rid="bb0190" ref-type="bibr">[38]</xref>, they discuss this issue in depth, and recommend a workflow for SLiM discovery that culminates in experimental validation, whether <italic>in vivo</italic> or <italic>in vitro</italic>. Working with viral–host systems adds layers of difficulty to experimental motif validation, so it should not be surprising or to the detriment of available information resources that viral SLiMs are less thoroughly documented.<table-wrap position="float" id="t0010"><label>Table 2</label><caption><p>Examples of Viral Proteins That Mimic Host SLiMs, updated from <xref rid="bb0025" ref-type="bibr">[5]</xref></p></caption><alt-text id="al0015">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Host target</th><th>Viral protein</th><th>Virus</th><th>Motif<xref rid="tf6020" ref-type="table-fn">a</xref></th><th>ELM</th></tr></thead><tbody><tr><td>CDH1</td><td>E1</td><td>BPV</td><td>KEN</td><td>DEG_APCC_KENbox_2</td></tr><tr><td>Phosphodegron FBW7</td><td>LT</td><td>SV40</td><td>TPxxE</td><td>DEG_SCF_FBW7_1</td></tr><tr><td>Phosphodegron βTrCP1</td><td>Vpu</td><td>HIV</td><td>DSGxxS</td><td>DEG_SCF_TrCP1_1</td></tr><tr><td>SIAH1</td><td>ORF45</td><td>KSHV</td><td>PxAxV</td><td>DEG_SIAH_1</td></tr><tr><td>Tankyrase</td><td>EBNA1</td><td>EBV</td><td>RxxPDG</td><td>DOC_ANK_TNKS_1</td></tr><tr><td>Cyclins</td><td>E1</td><td>HPV</td><td>RxLF</td><td>DOC_CYCLIN_1</td></tr><tr><td>PP1</td><td>γ134.5</td><td>HSV</td><td>RVxF</td><td>DOC_PP1</td></tr><tr><td>Calcineurin</td><td>p12</td><td>HTLV1</td><td>SPxLxLT</td><td>DOC_PP2B_1</td></tr><tr><td>USP7</td><td>EBNA1</td><td>EBV</td><td>PxE[ˆP]xS[ˆP]</td><td>DOC_USP7_MATH_2</td></tr><tr><td>14-3-3</td><td>Rep68</td><td>AAV</td><td>RSxSxP</td><td>LIG_14-3-3_CanoR_1</td></tr><tr><td>Clathrin heavy chain</td><td>HDAg-L</td><td>HDV</td><td>LFxAD</td><td>LIG_Clathr_ClatBox_1</td></tr><tr><td>TR</td><td>E1A</td><td>Adenovirus</td><td>LxxLIxxxL</td><td>LIG_CORNRBOX</td></tr><tr><td>CtBP SDB</td><td>E1A</td><td>Adenovirus</td><td>PxDLS</td><td>LIG_CtBP_PxDLS_1</td></tr><tr><td>Dynein light chain 8</td><td>P</td><td>Rabies</td><td>KxTQT</td><td>LIG_Dynein_DLC8_1</td></tr><tr><td>ALIX</td><td>Gag</td><td>HIV</td><td>LYPxxxL</td><td>LIG_LYPXL_L_2</td></tr><tr><td>BS69</td><td>EBNA2</td><td>EBV</td><td>PxLxP</td><td>LIG_MYND_1</td></tr><tr><td>PDZ domain</td><td>E6</td><td>HPV</td><td>TxV$</td><td>LIG_PDZ_Class_1</td></tr><tr><td>Tsg101</td><td>Gag</td><td>HIV</td><td>PTAP</td><td>LIG_PTAP_UEV_1</td></tr><tr><td>RB (pocket region)</td><td>E7</td><td>HPV</td><td>LxCxE</td><td>LIG_RB_LxCxE_1</td></tr><tr><td>RB (E2F competition)</td><td>E1A</td><td>Adenovirus</td><td>LxxLYD</td><td>LIG_RB_pABgroove_1</td></tr><tr><td>Integrin α5β3</td><td>VP1</td><td>FMDV</td><td>RGD</td><td>LIG_RGD</td></tr><tr><td>SH2 domain</td><td>stpC</td><td>HVS</td><td>YxxV</td><td>LIG_SH2</td></tr><tr><td>SH3 domain</td><td>Nef</td><td>HIV</td><td>PxxP</td><td>LIG_SH3_2</td></tr><tr><td>TRAF2</td><td>LMP1</td><td>EBV</td><td>PxQxT</td><td>LIG_TRAF2_1</td></tr><tr><td>TRAF6</td><td>U(L)37</td><td>HSV</td><td>PxExxE</td><td>LIG_TRAF6</td></tr><tr><td>Syk</td><td>LMP2A</td><td>EBV</td><td>Yxxϕ Yxxϕ</td><td>LIG_TYR_ITAM</td></tr><tr><td>Farnesyltransferase</td><td>HDAg-L</td><td>HDV</td><td>Cxxx$</td><td>MOD_CAAXbox</td></tr><tr><td>Oligosaccharyltransferase</td><td>E1</td><td>HCV</td><td>N[ˆP][ST]</td><td>MOD_N-GLC_1</td></tr><tr><td><italic>N</italic>-myristoyltransferase</td><td>G9R</td><td>Vaccinia</td><td>ˆGxxxS</td><td>MOD_Nmyristoyl</td></tr><tr><td>PIAS1</td><td>IE1</td><td>HCMV</td><td>IKxE</td><td>MOD_SUMO</td></tr><tr><td>AP-2μ</td><td>Env</td><td>SIV</td><td>Yxxϕ</td><td>TRG_ENDOCYTIC_2</td></tr><tr><td>COP1</td><td>E3</td><td>Adenovirus</td><td>KK</td><td>TRG_ER_diLys_1</td></tr><tr><td>ERD2</td><td>ctxA</td><td>Phage CTX</td><td>KDEL</td><td>TRG_ER_KDEL_1</td></tr><tr><td>AP-1</td><td>Nef</td><td>HIV</td><td>ExxxLL</td><td>TRG_LysEnd_APsAcLL_1</td></tr><tr><td>NESc</td><td>Rev</td><td>HIV</td><td>Ψ-rich</td><td>TRG_NES_CRM1_1</td></tr><tr><td>NLS, bipartite</td><td>PB2</td><td>Influenza</td><td>KR-rich</td><td>TRG_NLS_Bipartite_4</td></tr><tr><td>NLS, monopartite</td><td>LT</td><td>SV40</td><td>KR-rich</td><td>TRG_NLS_MonoCore_1</td></tr><tr><td>CtBP NDB</td><td>E1A</td><td>Adenovirus</td><td>RxxTG</td><td/></tr><tr><td>p300/CBP</td><td>E1A</td><td>Adenovirus</td><td>FxDxxxL</td><td/></tr><tr><td>Caspases</td><td>NS1</td><td>ADV</td><td>DxxD↓</td><td/></tr><tr><td>NEDD4</td><td>VP40</td><td>Ebola</td><td>PPxY</td><td/></tr><tr><td>SEC24C</td><td>VP40</td><td>Ebola</td><td>LxMVI</td><td/></tr><tr><td>JAK</td><td>LMP1</td><td>EBV</td><td>PxxPxP</td><td/></tr><tr><td>TRADD</td><td>LMP1</td><td>EBV</td><td>YYD$</td><td/></tr><tr><td>Elongin C</td><td>Vif</td><td>HIV</td><td>SLxxxLxxxI</td><td/></tr><tr><td>PACS1</td><td>Nef</td><td>HIV</td><td>EEEE</td><td/></tr><tr><td>HCF</td><td>VP16</td><td>HSV</td><td>EHxY</td><td/></tr><tr><td>NoLS</td><td>γ134.5</td><td>HSV</td><td>KR-rich</td><td/></tr><tr><td>Furin</td><td>Spike</td><td>IBV</td><td>R↓S</td><td/></tr><tr><td>PKR</td><td>NS1</td><td>Influenza</td><td>IMxKN</td><td/></tr><tr><td>H2A–H2B</td><td>LANA</td><td>KSHV</td><td>MxLRSG</td><td/></tr><tr><td>Palmitoyl acyltransferase</td><td>G</td><td>Rabies</td><td>CC</td><td/></tr></tbody></table><table-wrap-foot><fn id="tf6020"><label>a</label><p id="np6020">The down arrow (↓) indicates a cleavage site; φ (phi) represents a site occupied by a hydrophobic [VILFWYM] and Ψ (Psi) an aliphatic [VILM] AA. Other motif symbols are regular expression terms. For example, ˆ indicates sequence N terminus, but in brackets indicates negation. That is, [ˆP] indicates any AA except proline. Motifs stated do not necessarily correspond to the general motif patterns currently in ELM.</p></fn></table-wrap-foot></table-wrap></p>
      <p id="p0170">Searching arbitrary sequences for <bold>motif instances</bold> is computationally straightforward. <xref rid="b0015" ref-type="boxed-text">Box 3</xref>
provides an example of motif searching with ELM, which might facilitate comparative analysis of two related proteins from different species of human herpesvirus (HSV). Resources such as InterPro and UniProt are able to perform similar assessments, but give broader, domain-level representations with less functional detail than the SLiM searches enabled by ELM. Reports in the primary literature take a different approach, by marking SLiMs in a protein alignment, which includes orthologues to mark conservation (e.g., Figure 3 in <xref rid="bb0195" ref-type="bibr">[39]</xref>). The ELM-generated report combines predicted SLiMs with information from annotated domains and local disorder predictions, for a perspective that complements the other approaches.<boxed-text id="b0015"><label>Box 3</label><caption><title>Motif Searches Enable Comparison of Neurovirulence Proteins</title></caption><p id="p0065">HSV-1 and HSV-2 virulence factor ICP34.5 assists in viral immune evasion by molecular mimicry. HSV-1 neurovirulence protein ICP34.5, encoded by the γ34.5 gene, initiates immune interference by binding and sequestering cellular proteins that would stimulate autophagy, translational arrest, and type I interferon responses. HSV-1 ICP34.5 binds TANK-binding kinase 1 (TBK1) to prevent type I interferon induction <xref rid="bb0375" ref-type="bibr">[75]</xref>, Beclin-1 to prevent autophagy <xref rid="bb0380" ref-type="bibr">[76]</xref>, and both PP1α and eIF2α to overcome translational arrest <xref rid="bb0385" ref-type="bibr">[77]</xref>. HSV-2 γ34.5 contains an intron not present in HSV-1, and up to four isoforms of HSV-2 ICP34.5 are known <xref rid="bb0390" ref-type="bibr">[78]</xref>. Full-length HSV-2 ICP34.5 has conserved PP1α and eIF2α-binding domains, but lacks TBK1 and Beclin-1 binding domains <xref rid="bb0395" ref-type="bibr">[79]</xref>. Additional HSV-1 motifs influence intracellular localization <xref rid="bb0400" ref-type="bibr">[80]</xref>, virion maturation, and egress <xref rid="bb0405" ref-type="bibr">[81]</xref>, not yet characterized in HSV-2. HSV-2 is recognized as more virulent than HSV-1, but both can cause neuropathology, including viral encephalitis and meningitis <xref rid="bb0410" ref-type="bibr">[82]</xref>. To attenuate virulence, ICP34.5 is routinely deleted or inactivated when making HSV-1 constructs for oncolytic therapy <xref rid="bb0410" ref-type="bibr">[82]</xref>. Both are the same length and share domain structures, and partially share SLiM compositions (<xref rid="f0010" ref-type="fig">Figure I</xref>). Identifying differences in SLiMs from each could provide clues for more detailed experimental investigations to understand ICP34.5 virulence determinants and host protein targets.</p><p id="p0070">Searching ELM for motif instances in HSV-2 ICP34.5 (UniProt P28283) gives 127 instances of 39 motif classes, before filtering to exclude globular domains and other likely false hits. Filtering leaves 97 instances, which cover almost all of this 261 AA protein except for a predicted globular domain of 73 AAs. A similar query for the HSV-1 protein (UniProt P08353) gives 158 instances of 42 distinct motifs, and 114 instances of 36 motifs when filtered. Most of the ELM motif hits are probably false positives, if only because the motif expressions overlap. The patterns (.RK)|(RR[ˆKR]), [KR]R., and R...[KR]R., RRGPRRR, MSRRR, and RR all match sites in the first tenAA positions of the HSV-2 query protein sequence, a low-complexity region dominated by positively charged AAs. The HSV-1 version contains a 30 amino acid ATP triplet repeat at sites 160–190, not found in the HSV-2 protein. ELM matches four motifs here, only one of which (DOC_CKS1_1) is unique to HSV-1.<fig id="f0015"><label>Figure I</label><caption><p><bold>Viral SLiM Comparisons Using ELM.</bold> (A) ELM-generated plots of motif locations in neurovirulence factor ICP34.5 from HSV-1 and HSV-2 <xref rid="bb0370" ref-type="bibr">74</xref>, <xref rid="bb0415" ref-type="bibr">83</xref>. (B) Summary of motifs found in one or both.</p></caption><alt-text id="al0045">Figure I</alt-text><graphic xlink:href="b2a_lrg"/><graphic xlink:href="b2b_lrg"/></fig>
</p><notes notes-type="alt-text" specific-use="for-accessibility" id="al0040"><p>Alt-text: Box 3</p></notes></boxed-text></p>
      <p id="p0175">Clearly, false positives are inevitable among SLiM search results. This makes it necessary to filter for the most significant and informative outcomes. This leads to consideration of <italic>in silico</italic> (computational) methods for SLiM evaluation. A highly recommended, authoritative review of SLiM discovery techniques, from an author of the SLiMSuite software package, discusses motif identification techniques in depth <xref rid="bb0200" ref-type="bibr">[40]</xref>.</p>
    </sec>
  </sec>
  <sec id="s0035">
    <title>Motif Discovery</title>
    <p id="p0180">Methods for SLiM discovery can be divided into two broad classes: (i) <italic>de novo</italic> discovery of new SLiMs, and (ii) instance prediction to find new occurrences of known SLiMs. There are currently at least eight software packages available to discover new SLiMs and 40 packages (25 stand-alone programs or servers and two software suites that consist of multiple tools: SLiMSuite <xref rid="bb0200" ref-type="bibr">[40]</xref>, which includes ten utilities, and MEME <xref rid="bb0205" ref-type="bibr">[41]</xref>, which consists of five tools for SLiM instance detection). Though MEME was developed for discovery of DNA sequence motifs, it generates ungapped, profile-based motifs using the expectation–maximization (EM) algorithm. No single method is inherently better than the rest, but the choice of which to use depends on several factors, such as the input sequence data, whether one sequence, an alignment, or a collection of nonhomologous sequences <xref rid="bb0200" ref-type="bibr">[40]</xref>. To illustrate the diversity of motif discovery methods, this section mentions only a handful of the software tools available (<xref rid="t0015" ref-type="table">Table 3</xref>
). Readers seeking to learn more about the full set of alternatives are strongly encouraged to consult <xref rid="bb0200" ref-type="bibr">[40]</xref>, particularly Tables 1, 4, and 5 therein. Another helpful resource (Table 1 in <xref rid="bb0190" ref-type="bibr">[38]</xref>) lists online motif discovery bioinformatics services.<table-wrap position="float" id="t0015"><label>Table 3</label><caption><p>Computational Resources for SLiM Discovery</p></caption><alt-text id="al0020">Table 3</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Program</th><th>Website</th><th>Refs</th></tr></thead><tbody><tr><td>SLiMSuite</td><td><ext-link ext-link-type="uri" xlink:href="https://github.com/slimsuite/SLiMSuite" id="ir0010">https://github.com/slimsuite/SLiMSuite</ext-link></td><td><xref rid="bb0200" ref-type="bibr">[40]</xref></td></tr><tr><td>SLiMFinder</td><td><ext-link ext-link-type="uri" xlink:href="https://www.slimsuite.unsw.edu.au/servers/slimfinder.php" id="ir6000">https://www.slimsuite.unsw.edu.au/servers/slimfinder.php</ext-link></td><td><xref rid="bb0225" ref-type="bibr">[45]</xref></td></tr><tr><td>DILIMOT</td><td><ext-link ext-link-type="uri" xlink:href="https://dilimot.russelllab.org" id="ir6005">https://dilimot.russelllab.org</ext-link></td><td><xref rid="bb0230" ref-type="bibr">46</xref>, <xref rid="bb0235" ref-type="bibr">47</xref></td></tr><tr><td>GLAM2</td><td><ext-link ext-link-type="uri" xlink:href="https://meme-suite.org/tools/glam2" id="ir6030">https://meme-suite.org/tools/glam2</ext-link></td><td><xref rid="bb0240" ref-type="bibr">[48]</xref></td></tr><tr><td>NestedMica</td><td><ext-link ext-link-type="uri" xlink:href="https://www.mybiosoftware.com/nestedmica-0-8-0-motif-finder.html" id="ir7000">https://www.mybiosoftware.com/nestedmica-0-8-0-motif-finder.html</ext-link></td><td><xref rid="bb0245" ref-type="bibr">49</xref>, <xref rid="bb0250" ref-type="bibr">50</xref></td></tr><tr><td>ShettiMotif</td><td><ext-link ext-link-type="uri" xlink:href="http://sites.google.com/site/haithamsobhy/ShettiMotif_V1.zip" id="ir0030">https://sites.google.com/site/haithamsobhy/ShettiMotif_V1.zip</ext-link></td><td><xref rid="bb0280" ref-type="bibr">[56]</xref></td></tr></tbody></table></table-wrap></p>
    <sec id="s0040">
      <title><italic>De Novo</italic> Methods</title>
      <p id="p0185">Several alternative approaches for discovery of new motifs have been advanced. Edwards and Palopoli <xref rid="bb0200" ref-type="bibr">[40]</xref> review the alternatives in depth, discussing their merits and drawbacks. Briefly, they can be divided into alignment-based and alignment-free methods. An alignment-based approach looks for conserved sites among homologous sequences, but can be misled by high sequence conservation in globular domains. A program called SLiMPrints works around this with a specialized approach to model substitutions <xref rid="bb0210" ref-type="bibr">[42]</xref>. SLiMPrints uses a statistical model of relative local conservation, which looks for clusters of overly constrained sites in a window of about 30 AAs, using IUPred scores (intrinsically unordered prediction; see later) to weigh sites in <bold>intrinsically disordered protein</bold> regions more heavily than sites in globular (ordered) regimes <xref rid="bb0210" ref-type="bibr">[42]</xref>.</p>
      <p id="p0190">In contrast, alignment-free methods look for enrichment of amino acid patterns in proteins that are expected by other means to perform similar motif-related roles, for example, by GO category annotations or protein–protein interaction (PPI) data, that is, via databases that capture experimental evidence for protein colocalization and functional interactions. An important caveat is that to assume such sequences are independent could yield spurious enrichment of shared patterns, so alignment-free methods need to compensate for evolutionary constraints at the domain level, rather than for full-length homologous proteins. The development of such corrections and their relative advantages are detailed in <xref rid="bb0200" ref-type="bibr">[40]</xref>. Some programs (e.g., SLiMDisc <xref rid="bb0215" ref-type="bibr">[43]</xref>, SLiMFinder <xref rid="bb0220" ref-type="bibr">44</xref>, <xref rid="bb0225" ref-type="bibr">45</xref>, and DILIMOT <xref rid="bb0230" ref-type="bibr">46</xref>, <xref rid="bb0235" ref-type="bibr">47</xref>) produce regular expressions that compensate for phylogenetic relatedness, while others (MEME suite, GLAM2 <xref rid="bb0240" ref-type="bibr">[48]</xref>, and NestedMICA <xref rid="bb0245" ref-type="bibr">49</xref>, <xref rid="bb0250" ref-type="bibr">50</xref>) produce probabilistic profiles. For more discussion of these and issues of concern for computational motif discovery, see <xref rid="bb0200" ref-type="bibr">[40]</xref>.</p>
    </sec>
    <sec id="s0045">
      <title>Instance Detection</title>
      <p id="p0195">Filtering methods control high false positive rates from SLiM instance detection. Structural information, whether known or predicted, can be used for filtering. <xref rid="b0015" ref-type="boxed-text">Box 3</xref> illustrates how ELM filters results to exclude a region predicted to fold as globular protein. These predictions were made by SMART (simple modular architecture research tool) <xref rid="bb0255" ref-type="bibr">[51]</xref> and Pfam <xref rid="bb0260" ref-type="bibr">[52]</xref> domain matches, corroborated by GlobPlot <xref rid="bb0265" ref-type="bibr">[53]</xref>. Another widely used approach is to identify regions of local disorder, where protein structure is not clearly defined, making that region accessible to interact with other proteins. IUPred <xref rid="bb0270" ref-type="bibr">[54]</xref> is commonly used for this task, though the choice of parameter settings and how to interpret results varies. ELM results include an IUPred disorder score and a simple cutoff of 0.5 to define the disorder transition. Above this value, local protein structure is considered accessible for interaction with other proteins.</p>
      <p id="p0200">Scoring schemes filter for statistical enrichment of motif instances. An approach of filtering by homology <xref rid="bb0275" ref-type="bibr">[55]</xref> seems inappropriate for use to detect virus interactions with host proteins, as it may exclude nonhomologous regions with motifs that do interact, yielding false negatives. Regardless, failure to consider evolutionary relatedness among sequences being searched could introduce bias due to common ancestry, rather than independence, among sequences.</p>
      <p id="p0205">A simple approach to instance prediction is a stand-alone program called ShettiMotif <xref rid="bb0280" ref-type="bibr">[56]</xref>. It was used to scan 2251 protein sequences from 11 Poxviridae genomes (an average of 205 proteins per poxvirus) for low-complexity regions and regular expressions defined by PROSITE. The approach compared numbers of proteins per genome that carry each motif, and doubtlessly includes many motif instances that are not functional as SLiMs. Also, shorter motifs occur more frequently than longer motifs <xref rid="bb0015" ref-type="bibr">3</xref>, <xref rid="bb0135" ref-type="bibr">27</xref>, partly due to chance alone. Regardless, systematic error may be considered a source of background noise across the large number of proteins in 11 viral proteomes, each having different host specificities, to enable somewhat meaningful comparisons, in such a ‘statistical genomics’ approach <xref rid="bb0015" ref-type="bibr">[3]</xref>. The comparisons could be more meaningful if false positive motif instances were reduced.</p>
      <p id="p0210">Becerra <italic>et al.</italic> developed another approach to instance counting <xref rid="bb0285" ref-type="bibr">[57]</xref>, which involves comparison with a null distribution from permuting primary sequence and testing for presence of the motif in the permuted sequences. A motif is considered rare and therefore significantly unlikely to occur by chance if it is present at or below some cutoff frequency. Restricting the sequence region that is used for permutation testing, such as by use of structural considerations, can further focus the search. Indeed, such a hybrid filtering approach was described recently and evaluated on the HIV-1 proteome <xref rid="bb0285" ref-type="bibr">[57]</xref>. Following methods described in an earlier study <xref rid="bb0290" ref-type="bibr">[58]</xref>, Becerra <italic>et al.</italic> used IUPred with a modified, window-based scoring procedure to identify intrinsically disordered protein regions, and tested for statistical rarity below 1% of 1000 shuffled variants. The approach further considered conservation above 70% in a set of aligned sequences, though combining three filtering criteria was too stringent and excluded all motif candidates <xref rid="bb0285" ref-type="bibr">[57]</xref>.</p>
    </sec>
    <sec id="s0050">
      <title>Motif-Specific Databases</title>
      <p id="p0215">While algorithmic approaches seek to identify a broad range of SLiM types, more specialized resources have emerged to track the distribution of a particular SLiM in viral proteins. For example, iLIR@viral is a web resource dedicated to detecting LIR motif-containing proteins in viruses <xref rid="bb0295" ref-type="bibr">[59]</xref>. LC3-interacting regions (LIR motifs) are SLiMs that mediate protein–protein interactions involved in autophagy, as used by influenza A virus M2 protein to subvert autophagy and maintain virion stability <xref rid="bb0300" ref-type="bibr">[60]</xref>. Using curated text mining analysis and position-specific scoring matrices, iLIR@viral analyzed 16 609 reviewed viral sequences available from UniProt across 2569 individual viral species and found that 15 589 viral sequences contain LIR motifs. While many predicted instances may represent false positives, the enrichment of LIR motifs in viral sequences is consistent with viral adaptation to host xenophagy <xref rid="bb0175" ref-type="bibr">[35]</xref>. Curiously, ELM currently lists the LIR motif as a candidate, rather than an accepted motif class.</p>
    </sec>
  </sec>
  <sec id="s0055">
    <title>Concluding Remarks</title>
    <p id="p0220">Embedding SLiMs into engineered constructs may enable specific effects on cellular immune processes, for applications that include targeted drug delivery, pathogen-specific adjuvants, potent and broadly effective immunogens, transformational medical countermeasures, and improved design of vectors for gene therapy. SLiM modularity may enable easy ways to reprogram protein function with a few localized modifications. To realize the potential utility of SLiMs in synthetic biology, more research is needed to expand and integrate our collection of knowledge on viral SLiMs (see Outstanding Questions).</p>
    <p id="p0225">Detecting SLiMs in variant sequences may help to identify functional innovation or changes in virulence, in a manner that does not rely strictly on functional assessment at the whole-gene level, to identify how sequence-specific variation may interact with host responses. This may be particularly useful and important to understand new variants and assess the risk that they may spread and cause harmful effects on human health or agricultural interests. Such knowledge is needed in an era where synthetic biology may introduce new risks for biological error and biological terror. Detecting and understanding SLiM variants can help to reduce such risks and identify newly emerging threats to global health and security because watch lists for harmful organisms to ensure public safety by preventing access to select known risks may be inadequate <xref rid="bb0105" ref-type="bibr">21</xref>, <xref rid="bb0110" ref-type="bibr">22</xref>, <xref rid="bb0115" ref-type="bibr">23</xref>.</p>
    <p id="p0230">SLiMs in viral proteins can interact in many different ways with host proteins to modulate immune responses. A motif may be necessary but not sufficient for any inferred function. The simplest case is where a viral SLiM interacts directly with a host protein to yield an immunomodulated phenotype. More elaborate cases are known, such as the multifunctional proteins E1A (EBV), Nef (HIV-1), and ICP34.5 (HSV). Computational prediction of SLiM classes and new instances is a process, which involves experimental confirmation and validation. High-throughput methods for experimental assessment of protein interactions are useful to validate computational predictions <xref rid="bb0190" ref-type="bibr">38</xref>, <xref rid="bb0305" ref-type="bibr">61</xref>, and more assays are needed to evaluate functional and phenotypic effects of adding or deleting SLiMs.<boxed-text id="b0020"><label>Outstanding Questions</label><p id="p0235">What incentives or community-based activities would best enable integration of specialized viral gene ontologies with databases of motif classes and instances? To validate new SLiMs, what are the needed procedures, which simultaneously minimize spurious results and make the most promising candidates available to use and discover new instances?</p><p id="p0240">How prevalent are immunomodulatory motifs in viruses, relative to the prevalence of entire viral proteins dedicated to this specialized function? To what extent can viral immunomodulatory function be localized to a motif or domain, or is the larger whole-protein context necessary for function?</p><p id="p0245">What types of motif interactions are most common and important for viral <bold>immune modulation</bold>? Are they accurately reflected in the current literature and databases, or do many new types of motifs still await discovery?</p><p id="p0250">Is there sound support for an enrichment (or scarcity) of particular motif types in certain viral classes (i.e., Baltimore classification)? If so, what does this reveal about commonalities among viral replication strategies and potential for broad-spectrum antiviral treatments?</p><p id="p0255">What host countermeasures are involved with overcoming viral immune interference, either in general against many viruses, or in particular, against specific taxa? Do these countermeasures explain some of the crosstalk among interactions in antiviral innate signaling pathways?</p><p id="p0260">The distribution of glycosylation sites on enveloped viruses can be extremely variable, even within one host. Such variation may impede bioengineering specific constructs. How are SLiMs influenced by dynamic evolutionary processes? What fitness costs are associated with SLiM evolution? What specific constraints limit SLiM evolvability?</p><p id="p0265">What strategies are most effective to advance knowledge of viral immunomodulatory SLiMs in the design of vaccines and therapies to promote global health? For example, can some viral peptides be useful as adjuvants?</p><notes notes-type="alt-text" specific-use="for-accessibility" id="al0050"><p>Alt-text: Outstanding Questions</p></notes></boxed-text>
</p>
  </sec>
</body>
<back>
  <ref-list id="bi0005">
    <title>References</title>
    <ref id="bb0005">
      <label>1</label>
      <element-citation publication-type="journal" id="rf0005">
        <person-group person-group-type="author">
          <name>
            <surname>Garamszegi</surname>
            <given-names>S.</given-names>
          </name>
        </person-group>
        <article-title>Signatures of pleiotropy, economy and convergent evolution in a domain-resolved map of human–virus protein–protein interaction networks</article-title>
        <source>PLoS Pathog.</source>
        <volume>9</volume>
        <year>2013</year>
        <object-id pub-id-type="publisher-id">e1003778</object-id>
      </element-citation>
    </ref>
    <ref id="bb0010">
      <label>2</label>
      <element-citation publication-type="journal" id="rf0010">
        <person-group person-group-type="author">
          <name>
            <surname>Guven-Maiorov</surname>
            <given-names>E.</given-names>
          </name>
        </person-group>
        <article-title>Pathogen mimicry of host protein–protein interfaces modulates immunity</article-title>
        <source>Semin. Cell Dev. Biol.</source>
        <volume>58</volume>
        <year>2016</year>
        <fpage>136</fpage>
        <lpage>145</lpage>
        <pub-id pub-id-type="pmid">27287306</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0015">
      <label>3</label>
      <element-citation publication-type="journal" id="rf0015">
        <person-group person-group-type="author">
          <name>
            <surname>Hagai</surname>
            <given-names>T.</given-names>
          </name>
        </person-group>
        <article-title>Use of host-like peptide motifs in viral proteins is a prevalent strategy in host–virus interactions</article-title>
        <source>Cell Rep.</source>
        <volume>7</volume>
        <year>2014</year>
        <fpage>1729</fpage>
        <lpage>1739</lpage>
        <pub-id pub-id-type="pmid">24882001</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0020">
      <label>4</label>
      <element-citation publication-type="journal" id="rf0020">
        <person-group person-group-type="author">
          <name>
            <surname>Davey</surname>
            <given-names>N.E.</given-names>
          </name>
        </person-group>
        <article-title>SLiMSearch 2.0: biological context for short linear motifs in proteins</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>39</volume>
        <year>2011</year>
        <fpage>W56</fpage>
        <lpage>W60</lpage>
        <pub-id pub-id-type="pmid">21622654</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0025">
      <label>5</label>
      <element-citation publication-type="journal" id="rf0025">
        <person-group person-group-type="author">
          <name>
            <surname>Davey</surname>
            <given-names>N.E.</given-names>
          </name>
        </person-group>
        <article-title>How viruses hijack cell regulation</article-title>
        <source>Trends Biochem. Sci.</source>
        <volume>36</volume>
        <year>2011</year>
        <fpage>159</fpage>
        <lpage>169</lpage>
        <pub-id pub-id-type="pmid">21146412</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0030">
      <label>6</label>
      <element-citation publication-type="journal" id="rf0030">
        <person-group person-group-type="author">
          <name>
            <surname>Davey</surname>
            <given-names>N.E.</given-names>
          </name>
        </person-group>
        <article-title>Attributes of short linear motifs</article-title>
        <source>Mol. BioSyst.</source>
        <volume>8</volume>
        <year>2012</year>
        <fpage>268</fpage>
        <lpage>281</lpage>
        <pub-id pub-id-type="pmid">21909575</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0035">
      <label>7</label>
      <element-citation publication-type="journal" id="rf0035">
        <person-group person-group-type="author">
          <name>
            <surname>Via</surname>
            <given-names>A.</given-names>
          </name>
        </person-group>
        <article-title>How pathogens use linear motifs to perturb host cell networks</article-title>
        <source>Trends Biochem. Sci.</source>
        <volume>40</volume>
        <year>2015</year>
        <fpage>36</fpage>
        <lpage>48</lpage>
        <pub-id pub-id-type="pmid">25475989</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0040">
      <label>8</label>
      <element-citation publication-type="journal" id="rf0040">
        <person-group person-group-type="author">
          <name>
            <surname>Van Roey</surname>
            <given-names>K.</given-names>
          </name>
        </person-group>
        <article-title>Short linear motifs: ubiquitous and functionally diverse protein interaction modules directing cell regulation</article-title>
        <source>Chem. Rev.</source>
        <volume>114</volume>
        <year>2014</year>
        <fpage>6733</fpage>
        <lpage>6778</lpage>
        <pub-id pub-id-type="pmid">24926813</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0045">
      <label>9</label>
      <element-citation publication-type="journal" id="rf0045">
        <person-group person-group-type="author">
          <name>
            <surname>Tom</surname>
            <given-names>J.K.</given-names>
          </name>
        </person-group>
        <article-title>Applications of immunomodulatory immune synergies to adjuvant discovery and vaccine development</article-title>
        <source>Trends Biotechnol.</source>
        <volume>37</volume>
        <year>2019</year>
        <fpage>373</fpage>
        <lpage>388</lpage>
        <pub-id pub-id-type="pmid">30470547</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0050">
      <label>10</label>
      <element-citation publication-type="journal" id="rf0050">
        <person-group person-group-type="author">
          <name>
            <surname>Crispin</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Doores</surname>
            <given-names>K.J.</given-names>
          </name>
        </person-group>
        <article-title>Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design</article-title>
        <source>Curr. Opin. Virol.</source>
        <volume>11</volume>
        <year>2015</year>
        <fpage>63</fpage>
        <lpage>69</lpage>
        <pub-id pub-id-type="pmid">25747313</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0055">
      <label>11</label>
      <element-citation publication-type="journal" id="rf0055">
        <person-group person-group-type="author">
          <name>
            <surname>Crispin</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Structure and immune recognition of the HIV glycan shield</article-title>
        <source>Annu. Rev. Biophys.</source>
        <volume>47</volume>
        <year>2018</year>
        <fpage>499</fpage>
        <lpage>523</lpage>
        <pub-id pub-id-type="pmid">29595997</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0060">
      <label>12</label>
      <element-citation publication-type="journal" id="rf0060">
        <person-group person-group-type="author">
          <name>
            <surname>Wagh</surname>
            <given-names>K.</given-names>
          </name>
        </person-group>
        <article-title>Completeness of HIV-1 envelope glycan shield at transmission determines neutralization breadth</article-title>
        <source>Cell Rep.</source>
        <volume>25</volume>
        <year>2018</year>
        <fpage>893</fpage>
        <lpage>908</lpage>
        <pub-id pub-id-type="pmid">30355496</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0065">
      <label>13</label>
      <element-citation publication-type="journal" id="rf0065">
        <person-group person-group-type="author">
          <name>
            <surname>Seabright</surname>
            <given-names>G.E.</given-names>
          </name>
        </person-group>
        <article-title>Protein and glycan mimicry in HIV vaccine design</article-title>
        <source>J. Mol. Biol.</source>
        <volume>431</volume>
        <year>2019</year>
        <fpage>2223</fpage>
        <lpage>2247</lpage>
        <pub-id pub-id-type="pmid">31028779</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0070">
      <label>14</label>
      <element-citation publication-type="journal" id="rf0070">
        <person-group person-group-type="author">
          <name>
            <surname>Pawlak</surname>
            <given-names>E.N.</given-names>
          </name>
          <name>
            <surname>Dikeakos</surname>
            <given-names>J.D.</given-names>
          </name>
        </person-group>
        <article-title>HIV-1 Nef: a master manipulator of the membrane trafficking machinery mediating immune evasion</article-title>
        <source>Biochim. Biophys. Acta</source>
        <volume>1850</volume>
        <year>2015</year>
        <fpage>733</fpage>
        <lpage>741</lpage>
        <pub-id pub-id-type="pmid">25585010</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0075">
      <label>15</label>
      <element-citation publication-type="journal" id="rf0075">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>J.</given-names>
          </name>
        </person-group>
        <article-title>Immunogenicity and protection efficacy of monomeric and trimeric recombinant SARS coronavirus spike protein subunit vaccine candidates</article-title>
        <source>Viral Immunol.</source>
        <volume>26</volume>
        <year>2013</year>
        <fpage>126</fpage>
        <lpage>132</lpage>
        <pub-id pub-id-type="pmid">23573979</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0080">
      <label>16</label>
      <element-citation publication-type="journal" id="rf0080">
        <person-group person-group-type="author">
          <name>
            <surname>Lai</surname>
            <given-names>R.P.</given-names>
          </name>
        </person-group>
        <article-title>A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1</article-title>
        <source>J. Biol. Chem.</source>
        <volume>289</volume>
        <year>2014</year>
        <fpage>29912</fpage>
        <lpage>29926</lpage>
        <pub-id pub-id-type="pmid">25160627</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0085">
      <label>17</label>
      <element-citation publication-type="journal" id="rf0085">
        <person-group person-group-type="author">
          <name>
            <surname>Sliepen</surname>
            <given-names>K.</given-names>
          </name>
        </person-group>
        <article-title>Immunosilencing a highly immunogenic protein trimerization domain</article-title>
        <source>J. Biol. Chem.</source>
        <volume>290</volume>
        <year>2015</year>
        <fpage>7436</fpage>
        <lpage>7442</lpage>
        <pub-id pub-id-type="pmid">25635058</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0090">
      <label>18</label>
      <element-citation publication-type="journal" id="rf0090">
        <person-group person-group-type="author">
          <name>
            <surname>Wohlbold</surname>
            <given-names>T.J.</given-names>
          </name>
        </person-group>
        <article-title>Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses</article-title>
        <source>Vaccine</source>
        <volume>33</volume>
        <year>2015</year>
        <fpage>3314</fpage>
        <lpage>3321</lpage>
        <pub-id pub-id-type="pmid">26026378</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0095">
      <label>19</label>
      <element-citation publication-type="journal" id="rf0095">
        <person-group person-group-type="author">
          <name>
            <surname>Ruffini</surname>
            <given-names>P.A.</given-names>
          </name>
        </person-group>
        <article-title>Human chemokine MIP1α increases efficiency of targeted DNA fusion vaccines</article-title>
        <source>Vaccine</source>
        <volume>29</volume>
        <year>2010</year>
        <fpage>191</fpage>
        <lpage>199</lpage>
        <pub-id pub-id-type="pmid">21055498</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0100">
      <label>20</label>
      <element-citation publication-type="journal" id="rf0100">
        <person-group person-group-type="author">
          <name>
            <surname>Poggianella</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Dengue E protein domain III-based DNA immunisation induces strong antibody responses to all four viral serotypes</article-title>
        <source>PLoS Negl. Trop. Dis.</source>
        <volume>9</volume>
        <year>2015</year>
        <object-id pub-id-type="publisher-id">e0003947</object-id>
      </element-citation>
    </ref>
    <ref id="bb0105">
      <label>21</label>
      <element-citation publication-type="journal" id="rf0105">
        <person-group person-group-type="author">
          <name>
            <surname>DiEuliis</surname>
            <given-names>D.</given-names>
          </name>
        </person-group>
        <article-title>Options for synthetic DNA order screening, revisited</article-title>
        <source>mSphere</source>
        <volume>2</volume>
        <year>2017</year>
        <object-id pub-id-type="publisher-id">e00319-17</object-id>
      </element-citation>
    </ref>
    <ref id="bb0110">
      <label>22</label>
      <element-citation publication-type="journal" id="rf0110">
        <person-group person-group-type="author">
          <name>
            <surname>Wintle</surname>
            <given-names>B.C.</given-names>
          </name>
        </person-group>
        <article-title>A transatlantic perspective on 20 emerging issues in biological engineering</article-title>
        <source>Elife</source>
        <volume>6</volume>
        <year>2017</year>
        <object-id pub-id-type="publisher-id">e30247</object-id>
      </element-citation>
    </ref>
    <ref id="bb0115">
      <label>23</label>
      <element-citation publication-type="book" id="rf0115">
        <person-group person-group-type="author">
          <name>
            <surname>National Academies of Sciences, Engineering, and Medicine</surname>
          </name>
        </person-group>
        <chapter-title>Biodefense in the Age of Synthetic Biology</chapter-title>
        <year>2018</year>
        <publisher-name>The National Academies Press</publisher-name>
      </element-citation>
    </ref>
    <ref id="bb0120">
      <label>24</label>
      <element-citation publication-type="journal" id="rf0120">
        <person-group person-group-type="author">
          <name>
            <surname>Davey</surname>
            <given-names>N.E.</given-names>
          </name>
        </person-group>
        <article-title>Short linear motifs – <italic>ex nihilo</italic> evolution of protein regulation</article-title>
        <source>Cell Commun. Signal.</source>
        <volume>13</volume>
        <year>2015</year>
        <fpage>43</fpage>
        <pub-id pub-id-type="pmid">26589632</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0125">
      <label>25</label>
      <element-citation publication-type="journal" id="rf0125">
        <person-group person-group-type="author">
          <name>
            <surname>Chemes</surname>
            <given-names>L.B.</given-names>
          </name>
        </person-group>
        <article-title>Convergent evolution and mimicry of protein linear motifs in host-pathogen interactions</article-title>
        <source>Curr. Opin. Struct. Biol.</source>
        <volume>32</volume>
        <year>2015</year>
        <fpage>91</fpage>
        <lpage>101</lpage>
        <pub-id pub-id-type="pmid">25863584</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0130">
      <label>26</label>
      <element-citation publication-type="journal" id="rf0130">
        <person-group person-group-type="author">
          <name>
            <surname>Seo</surname>
            <given-names>M.-H.</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>P.M.</given-names>
          </name>
        </person-group>
        <article-title>The present and the future of motif-mediated protein–protein interactions</article-title>
        <source>Curr. Opin. Struct. Biol.</source>
        <volume>50</volume>
        <year>2018</year>
        <fpage>162</fpage>
        <lpage>170</lpage>
        <pub-id pub-id-type="pmid">29730529</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0135">
      <label>27</label>
      <element-citation publication-type="journal" id="rf0135">
        <person-group person-group-type="author">
          <name>
            <surname>Tompa</surname>
            <given-names>P.</given-names>
          </name>
        </person-group>
        <article-title>A million peptide motifs for the molecular biologist</article-title>
        <source>Mol. Cell</source>
        <volume>55</volume>
        <year>2014</year>
        <fpage>161</fpage>
        <lpage>169</lpage>
        <pub-id pub-id-type="pmid">25038412</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0140">
      <label>28</label>
      <element-citation publication-type="journal" id="rf0140">
        <person-group person-group-type="author">
          <name>
            <surname>Sobhy</surname>
            <given-names>H.</given-names>
          </name>
        </person-group>
        <article-title>A review of functional motifs utilized by viruses</article-title>
        <source>Proteomes</source>
        <volume>4</volume>
        <year>2016</year>
        <fpage>3</fpage>
      </element-citation>
    </ref>
    <ref id="bb0145">
      <label>29</label>
      <element-citation publication-type="journal" id="rf0145">
        <person-group person-group-type="author">
          <name>
            <surname>King</surname>
            <given-names>C.R.</given-names>
          </name>
        </person-group>
        <article-title>Hacking the cell: network intrusion and exploitation by adenovirus E1A</article-title>
        <source>mBio</source>
        <volume>9</volume>
        <year>2018</year>
        <object-id pub-id-type="publisher-id">e00390-18</object-id>
      </element-citation>
    </ref>
    <ref id="bb0150">
      <label>30</label>
      <element-citation publication-type="journal" id="rf0150">
        <person-group person-group-type="author">
          <name>
            <surname>Huntley</surname>
            <given-names>R.P.</given-names>
          </name>
        </person-group>
        <article-title>The GOA database: Gene Ontology annotation updates for 2015</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>43</volume>
        <year>2014</year>
        <fpage>D1057</fpage>
        <lpage>D1063</lpage>
        <pub-id pub-id-type="pmid">25378336</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0155">
      <label>31</label>
      <element-citation publication-type="book" id="rf0155">
        <person-group person-group-type="editor">
          <name>
            <surname>Dessimoz</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Škunca</surname>
            <given-names>N.</given-names>
          </name>
        </person-group>
        <source>The Gene Ontology Handbook (Methods in Molecular Biology, 1st edn)</source>
        <year>2017</year>
        <publisher-name>Humana Press</publisher-name>
      </element-citation>
    </ref>
    <ref id="bb0160">
      <label>32</label>
      <element-citation publication-type="journal" id="rf0160">
        <person-group person-group-type="author">
          <name>
            <surname>Binns</surname>
            <given-names>D.</given-names>
          </name>
        </person-group>
        <article-title>QuickGO: a web-based tool for Gene Ontology searching</article-title>
        <source>Bioinformatics</source>
        <volume>25</volume>
        <year>2009</year>
        <fpage>3045</fpage>
        <lpage>3046</lpage>
        <pub-id pub-id-type="pmid">19744993</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0165">
      <label>33</label>
      <element-citation publication-type="journal" id="rf0165">
        <person-group person-group-type="author">
          <name>
            <surname>Denny</surname>
            <given-names>P.</given-names>
          </name>
        </person-group>
        <article-title>Exploring autophagy with Gene Ontology</article-title>
        <source>Autophagy</source>
        <volume>14</volume>
        <year>2018</year>
        <fpage>419</fpage>
        <lpage>436</lpage>
        <pub-id pub-id-type="pmid">29455577</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0170">
      <label>34</label>
      <element-citation publication-type="journal" id="rf0170">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Y.</given-names>
          </name>
        </person-group>
        <article-title>Autophagy in negative-strand RNA virus infection</article-title>
        <source>Front. Microbiol.</source>
        <volume>9</volume>
        <year>2018</year>
        <fpage>1</fpage>
        <lpage>13</lpage>
        <pub-id pub-id-type="pmid">29403456</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0175">
      <label>35</label>
      <element-citation publication-type="journal" id="rf0175">
        <person-group person-group-type="author">
          <name>
            <surname>Choi</surname>
            <given-names>Y.</given-names>
          </name>
        </person-group>
        <article-title>Autophagy during viral infection – a double-edged sword</article-title>
        <source>Nat. Rev. Microbiol.</source>
        <volume>16</volume>
        <year>2018</year>
        <fpage>341</fpage>
        <lpage>354</lpage>
        <pub-id pub-id-type="pmid">29556036</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0180">
      <label>36</label>
      <element-citation publication-type="journal" id="rf0180">
        <person-group person-group-type="author">
          <name>
            <surname>Mitchell</surname>
            <given-names>A.L.</given-names>
          </name>
        </person-group>
        <article-title>InterPro in 2019: improving coverage, classification and access to protein sequence annotations</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>47</volume>
        <year>2019</year>
        <fpage>D351</fpage>
        <lpage>D360</lpage>
        <pub-id pub-id-type="pmid">30398656</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0185">
      <label>37</label>
      <element-citation publication-type="journal" id="rf0185">
        <person-group person-group-type="author">
          <name>
            <surname>Puntervoll</surname>
            <given-names>P.</given-names>
          </name>
        </person-group>
        <article-title>ELM server: a new resource for investigating short functional sites in modular eukaryotic proteins</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>31</volume>
        <year>2003</year>
        <fpage>3625</fpage>
        <lpage>3630</lpage>
        <pub-id pub-id-type="pmid">12824381</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0190">
      <label>38</label>
      <element-citation publication-type="journal" id="rf0190">
        <person-group person-group-type="author">
          <name>
            <surname>Gibson</surname>
            <given-names>T.J.</given-names>
          </name>
        </person-group>
        <article-title>Experimental detection of short regulatory motifs in eukaryotic proteins: tips for good practice as well as for bad</article-title>
        <source>Cell Commun. Signal.</source>
        <volume>13</volume>
        <year>2015</year>
        <fpage>42</fpage>
        <pub-id pub-id-type="pmid">26581338</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0195">
      <label>39</label>
      <element-citation publication-type="journal" id="rf0195">
        <person-group person-group-type="author">
          <name>
            <surname>Rojas</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>An eIF2α-binding motif in protein phosphatase 1 subunit GADD34 and its viral orthologs is required to promote dephosphorylation of eIF2α</article-title>
        <source>Proc. Natl. Acad. Sci. U. S. A.</source>
        <volume>112</volume>
        <year>2015</year>
        <fpage>E3466</fpage>
        <lpage>E3475</lpage>
        <pub-id pub-id-type="pmid">26100893</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0200">
      <label>40</label>
      <element-citation publication-type="book" id="rf0200">
        <person-group person-group-type="author">
          <name>
            <surname>Edwards</surname>
            <given-names>R.J.</given-names>
          </name>
          <name>
            <surname>Palopoli</surname>
            <given-names>N.</given-names>
          </name>
        </person-group>
        <chapter-title>Computational prediction of short linear motifs from protein sequences</chapter-title>
        <person-group person-group-type="editor">
          <name>
            <surname>Zhou</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>J.</given-names>
          </name>
        </person-group>
        <source>Computational Peptidology (Methods in Molecular Biology)</source>
        <year>2015</year>
        <publisher-name>Springer</publisher-name>
        <fpage>89</fpage>
        <lpage>141</lpage>
      </element-citation>
    </ref>
    <ref id="bb0205">
      <label>41</label>
      <element-citation publication-type="journal" id="rf0205">
        <person-group person-group-type="author">
          <name>
            <surname>Bailey</surname>
            <given-names>T.L.</given-names>
          </name>
        </person-group>
        <article-title>MEME SUITE: tools for motif discovery and searching</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>37</volume>
        <year>2009</year>
        <fpage>W202</fpage>
        <lpage>W208</lpage>
        <pub-id pub-id-type="pmid">19458158</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0210">
      <label>42</label>
      <element-citation publication-type="journal" id="rf0210">
        <person-group person-group-type="author">
          <name>
            <surname>Davey</surname>
            <given-names>N.E.</given-names>
          </name>
        </person-group>
        <article-title>SLiMPrints: conservation-based discovery of functional motif fingerprints in intrinsically disordered protein regions</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>40</volume>
        <year>2012</year>
        <fpage>10628</fpage>
        <lpage>10641</lpage>
        <pub-id pub-id-type="pmid">22977176</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0215">
      <label>43</label>
      <element-citation publication-type="journal" id="rf0215">
        <person-group person-group-type="author">
          <name>
            <surname>Davey</surname>
            <given-names>N.E.</given-names>
          </name>
        </person-group>
        <article-title>SLiMDisc: short, linear motif discovery, correcting for common evolutionary descent</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>34</volume>
        <year>2006</year>
        <fpage>3546</fpage>
        <lpage>3554</lpage>
        <pub-id pub-id-type="pmid">16855291</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0220">
      <label>44</label>
      <element-citation publication-type="journal" id="rf0220">
        <person-group person-group-type="author">
          <name>
            <surname>Edwards</surname>
            <given-names>R.J.</given-names>
          </name>
        </person-group>
        <article-title>SLiMFinder: a probabilistic method for identifying over-represented, convergently evolved, short linear motifs in proteins</article-title>
        <source>PLoS One</source>
        <volume>2</volume>
        <year>2007</year>
        <object-id pub-id-type="publisher-id">e967</object-id>
      </element-citation>
    </ref>
    <ref id="bb0225">
      <label>45</label>
      <element-citation publication-type="journal" id="rf0225">
        <person-group person-group-type="author">
          <name>
            <surname>Davey</surname>
            <given-names>N.E.</given-names>
          </name>
        </person-group>
        <article-title>SLiMFinder: a web server to find novel, significantly over-represented, short protein motifs</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>38</volume>
        <year>2010</year>
        <fpage>W534</fpage>
        <lpage>W539</lpage>
        <pub-id pub-id-type="pmid">20497999</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0230">
      <label>46</label>
      <element-citation publication-type="journal" id="rf0230">
        <person-group person-group-type="author">
          <name>
            <surname>Neduva</surname>
            <given-names>V.</given-names>
          </name>
        </person-group>
        <article-title>Systematic discovery of new recognition peptides mediating protein interaction networks</article-title>
        <source>PLoS Biol.</source>
        <volume>3</volume>
        <year>2005</year>
        <object-id pub-id-type="publisher-id">e405</object-id>
      </element-citation>
    </ref>
    <ref id="bb0235">
      <label>47</label>
      <element-citation publication-type="journal" id="rf0235">
        <person-group person-group-type="author">
          <name>
            <surname>Neduva</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Russell</surname>
            <given-names>R.B.</given-names>
          </name>
        </person-group>
        <article-title>DILIMOT: discovery of linear motifs in proteins</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>34</volume>
        <year>2006</year>
        <fpage>W350</fpage>
        <lpage>W355</lpage>
        <pub-id pub-id-type="pmid">16845024</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0240">
      <label>48</label>
      <element-citation publication-type="journal" id="rf0240">
        <person-group person-group-type="author">
          <name>
            <surname>Frith</surname>
            <given-names>M.C.</given-names>
          </name>
        </person-group>
        <article-title>Discovering sequence motifs with arbitrary insertions and deletions</article-title>
        <source>PLoS Comput. Biol.</source>
        <volume>4</volume>
        <year>2008</year>
        <object-id pub-id-type="publisher-id">e1000071</object-id>
      </element-citation>
    </ref>
    <ref id="bb0245">
      <label>49</label>
      <element-citation publication-type="journal" id="rf0245">
        <person-group person-group-type="author">
          <name>
            <surname>Down</surname>
            <given-names>T.A.</given-names>
          </name>
          <name>
            <surname>Hubbard</surname>
            <given-names>T.J.</given-names>
          </name>
        </person-group>
        <article-title>NestedMICA: sensitive inference of over-represented motifs in nucleic acid sequence</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>33</volume>
        <year>2005</year>
        <fpage>1445</fpage>
        <lpage>1453</lpage>
        <pub-id pub-id-type="pmid">15760844</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0250">
      <label>50</label>
      <element-citation publication-type="journal" id="rf0250">
        <person-group person-group-type="author">
          <name>
            <surname>Doğruel</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>NestedMICA as an <italic>ab initio</italic> protein motif discovery tool</article-title>
        <source>BMC Bioinformatics</source>
        <volume>9</volume>
        <year>2008</year>
        <fpage>19</fpage>
        <pub-id pub-id-type="pmid">18194537</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0255">
      <label>51</label>
      <element-citation publication-type="journal" id="rf0255">
        <person-group person-group-type="author">
          <name>
            <surname>Letunic</surname>
            <given-names>I.</given-names>
          </name>
        </person-group>
        <article-title>SMART: recent updates, new developments and status in 2015</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>43</volume>
        <year>2014</year>
        <fpage>D257</fpage>
        <lpage>D260</lpage>
        <pub-id pub-id-type="pmid">25300481</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0260">
      <label>52</label>
      <element-citation publication-type="journal" id="rf0260">
        <person-group person-group-type="author">
          <name>
            <surname>Finn</surname>
            <given-names>R.D.</given-names>
          </name>
        </person-group>
        <article-title>InterPro in 2017–beyond protein family and domain annotations</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>45</volume>
        <year>2016</year>
        <fpage>D190</fpage>
        <lpage>D199</lpage>
        <pub-id pub-id-type="pmid">27899635</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0265">
      <label>53</label>
      <element-citation publication-type="journal" id="rf0265">
        <person-group person-group-type="author">
          <name>
            <surname>Linding</surname>
            <given-names>R.</given-names>
          </name>
        </person-group>
        <article-title>GlobPlot: exploring protein sequences for globularity and disorder</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>31</volume>
        <year>2003</year>
        <fpage>3701</fpage>
        <lpage>3708</lpage>
        <pub-id pub-id-type="pmid">12824398</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0270">
      <label>54</label>
      <element-citation publication-type="journal" id="rf0270">
        <person-group person-group-type="author">
          <name>
            <surname>Dosztányi</surname>
            <given-names>Z.</given-names>
          </name>
        </person-group>
        <article-title>IUPred: web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content</article-title>
        <source>Bioinformatics</source>
        <volume>21</volume>
        <year>2005</year>
        <fpage>3433</fpage>
        <lpage>3434</lpage>
        <pub-id pub-id-type="pmid">15955779</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0275">
      <label>55</label>
      <element-citation publication-type="journal" id="rf0275">
        <person-group person-group-type="author">
          <name>
            <surname>Dinkel</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Sticht</surname>
            <given-names>H.</given-names>
          </name>
        </person-group>
        <article-title>A computational strategy for the prediction of functional linear peptide motifs in proteins</article-title>
        <source>Bioinformatics</source>
        <volume>23</volume>
        <year>2007</year>
        <fpage>3297</fpage>
        <lpage>3303</lpage>
        <pub-id pub-id-type="pmid">17977881</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0280">
      <label>56</label>
      <element-citation publication-type="journal" id="rf0280">
        <person-group person-group-type="author">
          <name>
            <surname>Sobhy</surname>
            <given-names>H.</given-names>
          </name>
        </person-group>
        <article-title>A bioinformatics pipeline to search functional motifs within whole-proteome data: a case study of poxviruses</article-title>
        <source>Virus Genes</source>
        <volume>53</volume>
        <year>2017</year>
        <fpage>173</fpage>
        <lpage>178</lpage>
        <pub-id pub-id-type="pmid">28000080</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0285">
      <label>57</label>
      <element-citation publication-type="journal" id="rf0285">
        <person-group person-group-type="author">
          <name>
            <surname>Becerra</surname>
            <given-names>A.</given-names>
          </name>
        </person-group>
        <article-title>Prediction of virus–host protein–protein interactions mediated by short linear motifs</article-title>
        <source>BMC Bioinformatics</source>
        <volume>18</volume>
        <year>2017</year>
        <fpage>163</fpage>
        <pub-id pub-id-type="pmid">28279163</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0290">
      <label>58</label>
      <element-citation publication-type="journal" id="rf0290">
        <person-group person-group-type="author">
          <name>
            <surname>Hagai</surname>
            <given-names>T.</given-names>
          </name>
        </person-group>
        <article-title>Intrinsic disorder in ubiquitination substrates</article-title>
        <source>J. Mol. Biol.</source>
        <volume>412</volume>
        <year>2011</year>
        <fpage>319</fpage>
        <lpage>324</lpage>
        <pub-id pub-id-type="pmid">21802429</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0295">
      <label>59</label>
      <element-citation publication-type="journal" id="rf0295">
        <person-group person-group-type="author">
          <name>
            <surname>Jacomin</surname>
            <given-names>A.-C.</given-names>
          </name>
        </person-group>
        <article-title>iLIR@viral: a web resource for LIR motif-containing proteins in viruses</article-title>
        <source>Autophagy</source>
        <volume>13</volume>
        <year>2017</year>
        <fpage>1782</fpage>
        <lpage>1789</lpage>
        <pub-id pub-id-type="pmid">28806134</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0300">
      <label>60</label>
      <element-citation publication-type="journal" id="rf0300">
        <person-group person-group-type="author">
          <name>
            <surname>Beale</surname>
            <given-names>R.</given-names>
          </name>
        </person-group>
        <article-title>A LC3-interacting motif in the influenza A virus M2 protein is required to subvert autophagy and maintain virion stability</article-title>
        <source>Cell Host Microbe</source>
        <volume>15</volume>
        <year>2014</year>
        <fpage>239</fpage>
        <lpage>247</lpage>
        <pub-id pub-id-type="pmid">24528869</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0305">
      <label>61</label>
      <element-citation publication-type="journal" id="rf0305">
        <person-group person-group-type="author">
          <name>
            <surname>Blikstad</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Ivarsson</surname>
            <given-names>Y.</given-names>
          </name>
        </person-group>
        <article-title>High-throughput methods for identification of protein–protein interactions involving short linear motifs</article-title>
        <source>Cell Commun. Signal.</source>
        <volume>13</volume>
        <year>2015</year>
        <fpage>38</fpage>
        <pub-id pub-id-type="pmid">26297553</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0310">
      <label>62</label>
      <element-citation publication-type="journal" id="rf0310">
        <person-group person-group-type="author">
          <name>
            <surname>Hulo</surname>
            <given-names>C.</given-names>
          </name>
        </person-group>
        <article-title>ViralZone: a knowledge resource to understand virus diversity</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>39</volume>
        <year>2010</year>
        <fpage>D576</fpage>
        <lpage>D582</lpage>
        <pub-id pub-id-type="pmid">20947564</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0315">
      <label>63</label>
      <element-citation publication-type="journal" id="rf0315">
        <person-group person-group-type="author">
          <name>
            <surname>Masson</surname>
            <given-names>P.</given-names>
          </name>
        </person-group>
        <article-title>ViralZone: recent updates to the virus knowledge resource</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>41</volume>
        <year>2012</year>
        <fpage>D579</fpage>
        <lpage>D583</lpage>
        <pub-id pub-id-type="pmid">23193299</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0320">
      <label>64</label>
      <element-citation publication-type="journal" id="rf0320">
        <person-group person-group-type="author">
          <name>
            <surname>Masson</surname>
            <given-names>P.</given-names>
          </name>
        </person-group>
        <article-title>An integrated ontology resource to explore and study host–virus relationships</article-title>
        <source>PLoS One</source>
        <volume>9</volume>
        <year>2014</year>
        <object-id pub-id-type="publisher-id">e108075</object-id>
      </element-citation>
    </ref>
    <ref id="bb0325">
      <label>65</label>
      <element-citation publication-type="journal" id="rf0325">
        <person-group person-group-type="author">
          <name>
            <surname>Foulger</surname>
            <given-names>R.</given-names>
          </name>
        </person-group>
        <article-title>Representing virus–host interactions and other multi-organism processes in the Gene Ontology</article-title>
        <source>BMC Microbiol.</source>
        <volume>15</volume>
        <year>2015</year>
        <fpage>146</fpage>
        <pub-id pub-id-type="pmid">26215368</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0330">
      <label>66</label>
      <element-citation publication-type="journal" id="rf0330">
        <person-group person-group-type="author">
          <name>
            <surname>Hulo</surname>
            <given-names>C.</given-names>
          </name>
        </person-group>
        <article-title>The ins and outs of eukaryotic viruses: knowledge base and ontology of a viral infection</article-title>
        <source>PLoS One</source>
        <volume>12</volume>
        <year>2017</year>
        <object-id pub-id-type="publisher-id">e0171746</object-id>
      </element-citation>
    </ref>
    <ref id="bb0335">
      <label>67</label>
      <element-citation publication-type="journal" id="rf0335">
        <person-group person-group-type="author">
          <name>
            <surname>The UniProt Consortium</surname>
          </name>
        </person-group>
        <article-title>UniProt: the universal protein knowledgebase</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>45</volume>
        <year>2017</year>
        <fpage>D158</fpage>
        <lpage>D169</lpage>
        <pub-id pub-id-type="pmid">27899622</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0340">
      <label>68</label>
      <element-citation publication-type="journal" id="rf0340">
        <person-group person-group-type="author">
          <name>
            <surname>McDonald</surname>
            <given-names>A.G.</given-names>
          </name>
          <name>
            <surname>Tipton</surname>
            <given-names>K.F.</given-names>
          </name>
        </person-group>
        <article-title>Fifty-five years of enzyme classification: advances and difficulties</article-title>
        <source>FEBS J.</source>
        <volume>281</volume>
        <year>2014</year>
        <fpage>583</fpage>
        <lpage>592</lpage>
        <pub-id pub-id-type="pmid">24103004</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0345">
      <label>69</label>
      <element-citation publication-type="journal" id="rf0345">
        <person-group person-group-type="author">
          <name>
            <surname>Dinkel</surname>
            <given-names>H.</given-names>
          </name>
        </person-group>
        <article-title>The eukaryotic linear motif resource ELM: 10 years and counting</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>42</volume>
        <year>2014</year>
        <fpage>D259</fpage>
        <lpage>D266</lpage>
        <pub-id pub-id-type="pmid">24214962</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0350">
      <label>70</label>
      <element-citation publication-type="journal" id="rf0350">
        <person-group person-group-type="author">
          <name>
            <surname>Dinkel</surname>
            <given-names>H.</given-names>
          </name>
        </person-group>
        <article-title>ELM 2016–data update and new functionality of the eukaryotic linear motif resource</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>44</volume>
        <year>2016</year>
        <fpage>D294</fpage>
        <lpage>D300</lpage>
        <pub-id pub-id-type="pmid">26615199</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0355">
      <label>71</label>
      <element-citation publication-type="journal" id="rf0355">
        <person-group person-group-type="author">
          <name>
            <surname>Dinkel</surname>
            <given-names>H.</given-names>
          </name>
        </person-group>
        <article-title>Phospho.ELM: a database of phosphorylation sites – update 2011</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>39</volume>
        <year>2011</year>
        <fpage>D261</fpage>
        <lpage>D267</lpage>
        <pub-id pub-id-type="pmid">21062810</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0360">
      <label>72</label>
      <element-citation publication-type="journal" id="rf0360">
        <person-group person-group-type="author">
          <name>
            <surname>Van Roey</surname>
            <given-names>K.</given-names>
          </name>
        </person-group>
        <article-title>The switches.ELM resource: a compendium of conditional regulatory interaction interfaces</article-title>
        <source>Sci. Signal.</source>
        <volume>6</volume>
        <year>2013</year>
        <fpage>rs7</fpage>
        <pub-id pub-id-type="pmid">23550212</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0365">
      <label>73</label>
      <element-citation publication-type="journal" id="rf0365">
        <person-group person-group-type="author">
          <name>
            <surname>Weatheritt</surname>
            <given-names>R.J.</given-names>
          </name>
        </person-group>
        <article-title>iELM – a web server to explore short linear motif-mediated interactions</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>40</volume>
        <year>2012</year>
        <fpage>W364</fpage>
        <lpage>W369</lpage>
        <pub-id pub-id-type="pmid">22638578</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0370">
      <label>74</label>
      <element-citation publication-type="journal" id="rf0370">
        <person-group person-group-type="author">
          <name>
            <surname>Gouw</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Exploring short linear motifs using the ELM database and tools</article-title>
        <source>Curr. Protoc. Bioinformatics</source>
        <volume>58</volume>
        <year>2017</year>
        <fpage>8.22.1</fpage>
        <lpage>8.22.35</lpage>
      </element-citation>
    </ref>
    <ref id="bb0375">
      <label>75</label>
      <element-citation publication-type="journal" id="rf0375">
        <person-group person-group-type="author">
          <name>
            <surname>Verpooten</surname>
            <given-names>D.</given-names>
          </name>
        </person-group>
        <article-title>Control of TANK-binding kinase 1-mediated signaling by the γ<sub>1</sub>34.5 protein of herpes simplex virus 1</article-title>
        <source>J. Biol. Chem.</source>
        <volume>284</volume>
        <year>2009</year>
        <fpage>1097</fpage>
        <lpage>1105</lpage>
        <pub-id pub-id-type="pmid">19010780</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0380">
      <label>76</label>
      <element-citation publication-type="journal" id="rf0380">
        <person-group person-group-type="author">
          <name>
            <surname>Orvedahl</surname>
            <given-names>A.</given-names>
          </name>
        </person-group>
        <article-title>HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein</article-title>
        <source>Cell Host Microbe</source>
        <volume>1</volume>
        <year>2007</year>
        <fpage>23</fpage>
        <lpage>35</lpage>
        <pub-id pub-id-type="pmid">18005679</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0385">
      <label>77</label>
      <element-citation publication-type="journal" id="rf0385">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>C.</given-names>
          </name>
        </person-group>
        <article-title>A conserved domain of herpes simplex virus ICP34.5 regulates protein phosphatase complex in mammalian cells</article-title>
        <source>FEBS Lett.</source>
        <volume>582</volume>
        <year>2008</year>
        <fpage>171</fpage>
        <lpage>176</lpage>
        <pub-id pub-id-type="pmid">18068675</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0390">
      <label>78</label>
      <element-citation publication-type="journal" id="rf0390">
        <person-group person-group-type="author">
          <name>
            <surname>Korom</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Up to four distinct polypeptides are produced from the γ34.5 open reading frame of herpes simplex virus 2</article-title>
        <source>J. Virol.</source>
        <volume>88</volume>
        <year>2014</year>
        <fpage>11284</fpage>
        <lpage>11296</lpage>
        <pub-id pub-id-type="pmid">25031346</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0395">
      <label>79</label>
      <element-citation publication-type="journal" id="rf0395">
        <person-group person-group-type="author">
          <name>
            <surname>Davis</surname>
            <given-names>K.L.</given-names>
          </name>
        </person-group>
        <article-title>Herpes simplex virus 2 ICP34.5 confers neurovirulence by regulating the type I interferon response</article-title>
        <source>Virology</source>
        <volume>468–470</volume>
        <year>2014</year>
        <fpage>330</fpage>
        <lpage>339</lpage>
      </element-citation>
    </ref>
    <ref id="bb0400">
      <label>80</label>
      <element-citation publication-type="journal" id="rf0400">
        <person-group person-group-type="author">
          <name>
            <surname>Mao</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Rosenthal</surname>
            <given-names>K.S.</given-names>
          </name>
        </person-group>
        <article-title>An N-terminal arginine-rich cluster and a proline-alanine-threonine repeat region determine the cellular localization of the herpes simplex virus type 1 ICP34.5 protein and its ligand, protein phosphatase 1</article-title>
        <source>J. Biol. Chem.</source>
        <volume>277</volume>
        <year>2002</year>
        <fpage>11423</fpage>
        <lpage>11431</lpage>
        <pub-id pub-id-type="pmid">11788604</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0405">
      <label>81</label>
      <element-citation publication-type="journal" id="rf0405">
        <person-group person-group-type="author">
          <name>
            <surname>Jing</surname>
            <given-names>X.</given-names>
          </name>
        </person-group>
        <article-title>Replication of herpes simplex virus 1 depends on the γ<sub>1</sub>134.5 functions that facilitate virus response to interferon and egress in the different stages of productive infection</article-title>
        <source>J. Virol.</source>
        <volume>78</volume>
        <year>2004</year>
        <fpage>7653</fpage>
        <lpage>7666</lpage>
        <pub-id pub-id-type="pmid">15220440</pub-id>
      </element-citation>
    </ref>
    <ref id="bb0410">
      <label>82</label>
      <element-citation publication-type="journal" id="rf0410">
        <person-group person-group-type="author">
          <name>
            <surname>Wilcox</surname>
            <given-names>D.R.</given-names>
          </name>
          <name>
            <surname>Longnecker</surname>
            <given-names>R.</given-names>
          </name>
        </person-group>
        <article-title>The herpes simplex virus neurovirulence factor γ34. 5: revealing virus–host interactions</article-title>
        <source>PLoS Pathog.</source>
        <volume>12</volume>
        <year>2016</year>
        <object-id pub-id-type="publisher-id">e1005449</object-id>
      </element-citation>
    </ref>
    <ref id="bb0415">
      <label>83</label>
      <element-citation publication-type="journal" id="rf0415">
        <person-group person-group-type="author">
          <name>
            <surname>Gould</surname>
            <given-names>C.M.</given-names>
          </name>
        </person-group>
        <article-title>ELM: the status of the 2010 eukaryotic linear motif resource</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>38</volume>
        <year>2010</year>
        <fpage>D167</fpage>
        <lpage>D180</lpage>
        <pub-id pub-id-type="pmid">19920119</pub-id>
      </element-citation>
    </ref>
  </ref-list>
  <glossary id="gl0005">
    <title>Glossary</title>
    <def-list id="gs0005">
      <def-item id="ge0005">
        <term>
          <bold>Adjuvant</bold>
        </term>
        <def>
          <p>an additive to a vaccine that promotes nonspecific immune responses. When administered together with an antigen, it induces more potent responses than the antigen alone.</p>
        </def>
      </def-item>
      <def-item id="ge0010">
        <term>
          <bold>Autophagy</bold>
        </term>
        <def>
          <p>an evolutionarily conserved degradation system for maintaining cellular homeostasis and innate immunity to clear pathogens from cells.</p>
        </def>
      </def-item>
      <def-item id="ge0015">
        <term>
          <bold>Domain</bold>
        </term>
        <def>
          <p>structure-based modular subunit of a protein, often with a specific function. Domains are generally larger and associated with structural subunits, while motifs are shorter and associated with intrinsically disordered protein regions.</p>
        </def>
      </def-item>
      <def-item id="ge0020">
        <term>
          <bold>ELM</bold>
        </term>
        <def>
          <p>the eukaryotic linear motif resource (<ext-link ext-link-type="uri" xlink:href="http://elm.eu.org" id="ir0065">elm.eu.org</ext-link>), a repository of known SLiMs; includes annotation from primary literature and information about experimental assays used.</p>
        </def>
      </def-item>
      <def-item id="ge0025">
        <term>
          <bold>Glycosylation</bold>
        </term>
        <def>
          <p>post-translational modification by host transferases linking sugar molecules to side chains of either nitrogen (<italic>N</italic>-linked) in asparagine or oxygen (<italic>O</italic>-linked) in serine or threonine. Viral proteins like HIV-1 envelope can be heavily glycosylated, providing camouflage against immune recognition, shifting as the PNG sequon mutates.</p>
        </def>
      </def-item>
      <def-item id="ge0030">
        <term>
          <bold>GO</bold>
        </term>
        <def>
          <p>Gene Ontology, an ontology for genetic products of any and all organisms, providing a framework to annotate gene and protein functions in genetic sequence databases and bioinformatics analysis procedures. GO includes multiple dimensions to capture biological complexity in adequate depth: molecular function, cellular component, and biological process. GO development is conducted by a consortium of research communities and databases, which regularly solicits input and feedback from the broader research community.</p>
        </def>
      </def-item>
      <def-item id="ge0035">
        <term>
          <bold>Immune modulation</bold>
        </term>
        <def>
          <p>interference with an immune-related process by a pathogen.</p>
        </def>
      </def-item>
      <def-item id="ge6045">
        <term>
          <bold>Intrinsically disordered protein/domain</bold>
        </term>
        <def>
          <p>regions of a protein sequence that are predicted or experimentally shown not to form consistent structure, e.g., α helices or β sheets. Such regions tend to be more accessible for interactions with other proteins.</p>
        </def>
      </def-item>
      <def-item id="ge0045">
        <term>
          <bold>Molecular mimicry</bold>
        </term>
        <def>
          <p>structural similarity that enables repurposing or hijacking of molecular function by pathogens, such as viruses. Molecular mimicry varies in extent from entire globular proteins, to localized domains, down to short linear motifs.</p>
        </def>
      </def-item>
      <def-item id="ge0050">
        <term>
          <bold>Motif class</bold>
        </term>
        <def>
          <p>a regular expression that summarizes known variants to define a sequence motif.</p>
        </def>
      </def-item>
      <def-item id="ge0055">
        <term>
          <bold>Motif instance</bold>
        </term>
        <def>
          <p>a particular motif as found in a protein or translated genetic sequence from a specific organism, strain, or isolate.</p>
        </def>
      </def-item>
      <def-item id="ge0060">
        <term>
          <bold>Ontology</bold>
        </term>
        <def>
          <p>a representation of domain-specific knowledge organized as concepts, their properties, and their relationships.</p>
        </def>
      </def-item>
      <def-item id="ge0065">
        <term>
          <bold>PNG sequon</bold>
        </term>
        <def>
          <p>three AA motif N[ˆP][ST], that is, asparagine, then any AA except proline, then serine or threonine, recognized by glycosyltransferase as a potential <italic>N</italic>-linked glycosylation site.</p>
        </def>
      </def-item>
      <def-item id="ge0070">
        <term>
          <bold>Regular expression</bold>
        </term>
        <def>
          <p>a string of characters that concisely represents many alternative sequence variants; may include wildcards to represent any character, groupings of possible characters, repetition, negation, start and end of sequence, etc.</p>
        </def>
      </def-item>
      <def-item id="ge0075">
        <term>
          <bold>Short linear motif (SLiM)</bold>
        </term>
        <def>
          <p>also known as MiniMotifs or MoRFs (molecular recognition features). Frequently represented as regular expressions, typically three to tenAAs long.</p>
        </def>
      </def-item>
      <def-item id="ge0080">
        <term>
          <bold>ViralZone</bold>
        </term>
        <def>
          <p>a knowledge base (<ext-link ext-link-type="uri" xlink:href="https://viralzone.expasy.org" id="ir0070">https://viralzone.expasy.org</ext-link>) that documents viral families, genome architectures, proteins, host–protein interactions, and an ontology for the functions of viral proteins.</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <ack id="ac0005">
    <title>Acknowledgments</title>
    <p id="p0270">LA-UR-18-26869. Los Alamos National Laboratory, an affirmative action/equal opportunity employer, is operated by Triad National Security, LLC, for the National Nuclear Security Administration of the US Department of Energy under contract 89233218CNA000001. We gratefully acknowledge funding support from the <funding-source id="gts0005">Functional Genomic and Computational Assessment of Threats</funding-source> (Fun GCAT) program of the Intelligence <funding-source id="gts0010"><institution-wrap><institution-id institution-id-type="doi">10.13039/100009224</institution-id><institution>Advanced Research Projects Agency</institution></institution-wrap></funding-source>, <funding-source id="gts0015"><institution-wrap><institution-id institution-id-type="doi">10.13039/100011038</institution-id><institution>Office of the Director of National Intelligence</institution></institution-wrap></funding-source>. The views and conclusions contained herein are those of the authors, and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Agency (IARPA), Los Alamos National Laboratory (LANL), Department of Energy (DOE), SRI International, or the US Government.</p>
  </ack>
</back>
